<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">54782</article-id><article-id pub-id-type="doi">10.7554/eLife.54782</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group></article-categories><title-group><article-title>Epigenetic regulation of <italic>Wnt7b</italic> expression by the <italic>cis</italic>-acting long noncoding RNA Lnc-Rewind in muscle stem cells</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes" id="author-170007"><name><surname>Cipriano</surname><given-names>Andrea</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-0775-3198</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/><xref ref-type="fn" rid="pa1">‡</xref></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-170008"><name><surname>Macino</surname><given-names>Martina</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-8730-9005</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-170009"><name><surname>Buonaiuto</surname><given-names>Giulia</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-4099-2433</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-170010"><name><surname>Santini</surname><given-names>Tiziana</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-170011"><name><surname>Biferali</surname><given-names>Beatrice</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-2399-885X</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-170012"><name><surname>Peruzzi</surname><given-names>Giovanna</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-170013"><name><surname>Colantoni</surname><given-names>Alessio</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-170014"><name><surname>Mozzetta</surname><given-names>Chiara</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-7147-7266</contrib-id><email>chiara.mozzetta@uniroma1.it</email><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund8"/><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-169738"><name><surname>Ballarino</surname><given-names>Monica</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-8595-7105</contrib-id><email>monica.ballarino@uniroma1.it</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution>Department of Biology and Biotechnology Charles Darwin, Sapienza University of Rome</institution><addr-line><named-content content-type="city">Rome</named-content></addr-line><country>Italy</country></aff><aff id="aff2"><label>2</label><institution>Institute of Molecular Biology and Pathology (IBPM), National Research Council (CNR) at Sapienza University of Rome</institution><addr-line><named-content content-type="city">Rome</named-content></addr-line><country>Italy</country></aff><aff id="aff3"><label>3</label><institution>Center for Life Nano Science at Sapienza, Istituto Italiano di Tecnologia</institution><addr-line><named-content content-type="city">Rome</named-content></addr-line><country>Italy</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Lee</surname><given-names>Jeannie T</given-names></name><role>Reviewing Editor</role><aff><institution>Massachusetts General Hospital</institution><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Struhl</surname><given-names>Kevin</given-names></name><role>Senior Editor</role><aff><institution>Harvard Medical School</institution><country>United States</country></aff></contrib></contrib-group><author-notes><fn fn-type="present-address" id="pa1"><label>‡</label><p>Department of Obstetrics &amp; Gynecology, Stanford University, Stanford, United States</p></fn><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date date-type="publication" publication-format="electronic"><day>12</day><month>01</month><year>2021</year></pub-date><pub-date pub-type="collection"><year>2021</year></pub-date><volume>10</volume><elocation-id>e54782</elocation-id><history><date date-type="received" iso-8601-date="2019-12-30"><day>30</day><month>12</month><year>2019</year></date><date date-type="accepted" iso-8601-date="2021-01-11"><day>11</day><month>01</month><year>2021</year></date></history><permissions><copyright-statement>© 2021, Cipriano et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Cipriano et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-54782-v2.pdf"/><abstract><p>Skeletal muscle possesses an outstanding capacity to regenerate upon injury due to the adult muscle stem cell (MuSC) activity. This ability requires the proper balance between MuSC expansion and differentiation, which is critical for muscle homeostasis and contributes, if deregulated, to muscle diseases. Here, we functionally characterize a novel chromatin-associated long noncoding RNA (lncRNA), Lnc-Rewind, which is expressed in murine MuSCs and conserved in human. We find that, in mouse, Lnc-Rewind acts as an epigenetic regulator of MuSC proliferation and expansion by influencing the expression of skeletal muscle genes and several components of the WNT (Wingless-INT) signalling pathway. Among them, we identified the nearby Wnt7b gene as a direct Lnc-Rewind target. We show that Lnc-Rewind interacts with the G9a histone lysine methyltransferase and mediates the in cis repression of Wnt7b by H3K9me2 deposition. Overall, these findings provide novel insights into the epigenetic regulation of adult muscle stem cells fate by lncRNAs.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>ncRNA</kwd><kwd>LncRNA</kwd><kwd>epigenetics</kwd><kwd>chromatin</kwd><kwd>muscle stem cells</kwd><kwd>Wnt7b</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004271</institution-id><institution>Sapienza Università di Roma</institution></institution-wrap></funding-source><award-id>prot. RM11715C7C8176C1</award-id><principal-award-recipient><name><surname>Ballarino</surname><given-names>Monica</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004271</institution-id><institution>Sapienza Università di Roma</institution></institution-wrap></funding-source><award-id>prot. RM11916B7A39DCE5</award-id><principal-award-recipient><name><surname>Ballarino</surname><given-names>Monica</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003407</institution-id><institution>Ministero dell’Istruzione, dell’Università e della Ricerca</institution></institution-wrap></funding-source><award-id>RBSI14QMG0</award-id><principal-award-recipient><name><surname>Mozzetta</surname><given-names>Chiara</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100005010</institution-id><institution>Associazione Italiana per la Ricerca sul Cancro</institution></institution-wrap></funding-source><award-id>MyFIRST grant n.18993</award-id><principal-award-recipient><name><surname>Mozzetta</surname><given-names>Chiara</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004923</institution-id><institution>AFM-Téléthon</institution></institution-wrap></funding-source><award-id>#22489</award-id><principal-award-recipient><name><surname>Mozzetta</surname><given-names>Chiara</given-names></name></principal-award-recipient></award-group><award-group id="fund8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100009880</institution-id><institution>Regione Lazio</institution></institution-wrap></funding-source><award-id><bold><italic>POR FESR LAZIO 2014, Project</italic> </bold>“RESEARCH&quot;</award-id><principal-award-recipient><name><surname>Mozzetta</surname><given-names>Chiara</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>The epigenetic regulation of adult muscle stem cell fate by lnc-Rewind relies on the RNA-mediated recruitment of G9a methyltransferase on the Wnt7b genomic locus.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>The transcriptional output of all organisms was recently found to be more complex than originally imagined, as the majority of the genomic content is pervasively transcribed into a diverse range of regulatory short and long non-protein coding RNAs (ncRNAs) (<xref ref-type="bibr" rid="bib1">Abugessaisa et al., 2017</xref>; <xref ref-type="bibr" rid="bib13">Carninci et al., 2005</xref>; <xref ref-type="bibr" rid="bib15">Cipriano and Ballarino, 2018</xref>). Among them, long noncoding RNAs (lncRNAs) are operationally defined as transcripts longer than 200 nucleotides, which display little or no protein coding potential. Since the initial discovery, numerous studies have demonstrated their contribution to many biological processes, including pluripotency, cell differentiation, and organism development (<xref ref-type="bibr" rid="bib6">Ballarino et al., 2016</xref>; <xref ref-type="bibr" rid="bib21">Fatica and Bozzoni, 2014</xref>). LncRNAs were demonstrated to regulate gene expression at transcriptional, post-transcriptional, or translational level. The function and the mechanisms of action are different and primarily depend on their (nuclear or cytoplasmic) subcellular localization (<xref ref-type="bibr" rid="bib12">Carlevaro et al., 2019</xref>; <xref ref-type="bibr" rid="bib47">Rinn and Chang, 2012</xref>; <xref ref-type="bibr" rid="bib54">Ulitsky and Bartel, 2013</xref>). A large number of lncRNAs localize inside the nucleus, either enriched on the chromatin or restricted to specific nucleoplasmic foci (<xref ref-type="bibr" rid="bib20">Engreitz et al., 2016</xref>; <xref ref-type="bibr" rid="bib53">Sun et al., 2018</xref>). In this location, they have the capacity to control the expression of neighbouring (in cis) or distant (in trans) genes by regulating their chromatin environment and also acting as structural scaffolds of nuclear domains (<xref ref-type="bibr" rid="bib28">Kopp and Mendell, 2018</xref>). Among the most important functions proposed for <italic>cis</italic>-acting lncRNAs, there is their ability to regulate transcription by recruiting repressing or activating epigenetic complexes to specific genomic loci (<xref ref-type="bibr" rid="bib26">Huarte et al., 2010</xref>; <xref ref-type="bibr" rid="bib34">Maamar et al., 2013</xref>; <xref ref-type="bibr" rid="bib35">McHugh et al., 2015</xref>; <xref ref-type="bibr" rid="bib57">Wang et al., 2011</xref>).</p><p>In muscle, high-throughput transcriptome sequencing (RNA-seq) and differential expression analyses have facilitated the discovery of several lncRNAs that are modulated during the different stages of skeletal myogenesis and dysregulated in muscle disorders (<xref ref-type="bibr" rid="bib6">Ballarino et al., 2016</xref>; <xref ref-type="bibr" rid="bib33">Lu et al., 2013</xref>; <xref ref-type="bibr" rid="bib61">Zhao et al., 2019</xref>). Although the roles of these transcripts have been partially identified, we are still far from a complete understanding of their mechanisms of action. For instance, the knowledge of the lncRNAs impact on adult muscle stem cell (MuSC) biology is partial and only a few examples have been characterized as functionally important. In the cytoplasm, the lncRNA <italic>Lnc-mg</italic> has been shown to regulate MuSC differentiation by acting as a sponge for <italic>Mir125b</italic> (<xref ref-type="bibr" rid="bib62">Zhu et al., 2017</xref>). In the nucleus, the lncRNA <italic>Dubr</italic> was found to promote satellite cell differentiation by recruiting Dnmts to the developmental pluripotency-associated 2 (<italic>Dppa2</italic>) promoter, leading to CpG hypermethylation and silencing (<xref ref-type="bibr" rid="bib58">Wang et al., 2015</xref>). In mouse, we have previously identified several lncRNAs specifically expressed during muscle in vitro differentiation and with either nuclear or cytoplasmic localization (<xref ref-type="bibr" rid="bib5">Ballarino et al., 2015</xref>). Among them, we found Lnc-Rewind (<bold>Re</bold>pressor of <bold>w</bold>nt <bold>ind</bold>uction), a chromatin-associated lncRNA conserved in human and expressed in proliferating C<sub>2</sub>C<sub>12</sub> myoblasts.</p><p>Here, we provide evidence on the role of Lnc-Rewind in the epigenetic regulation of the WNT (Wingless-INT) signalling in muscle cells. The WNT transduction cascade has been demonstrated to act as a conserved regulator of stem cell function via canonical (β-CATENIN) and non-canonical (planar cell polarity and calcium) signalling, and dysregulation of its activity has been reported in various developmental disorders and diseases (<xref ref-type="bibr" rid="bib41">Nusse and Clevers, 2017</xref>). In the muscle stem cell niche, WNT signalling is key in coordinating MuSC transitions from quiescence, proliferation, commitment, and differentiation (<xref ref-type="bibr" rid="bib10">Brack et al., 2008</xref>; <xref ref-type="bibr" rid="bib19">Eliazer et al., 2019</xref>; <xref ref-type="bibr" rid="bib29">Lacour et al., 2017</xref>; <xref ref-type="bibr" rid="bib30">Le Grand et al., 2009</xref>; <xref ref-type="bibr" rid="bib44">Parisi et al., 2015</xref>; <xref ref-type="bibr" rid="bib50">Rudolf et al., 2016</xref>). Because of this central role, the WNT pathway is supervised by several mechanisms and different works have shown that lncRNAs can modulate it at both transcriptional and post-transcriptional levels (<xref ref-type="bibr" rid="bib59">Zarkou et al., 2018</xref>). Here, we provide evidence that Lnc-Rewind associates with the H3K9 methyltransferase G9a to regulate the deposition of H3K9me2 in cis on the nearby <italic>Wnt7b</italic> gene. Our data show that Lnc-Rewind expression is necessary to maintain <italic>Wnt7b</italic> repressed and to allow MuSC expansion and proper differentiation.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Lnc-Rewind is a conserved chromatin-associated lncRNA expressed in satellite cells</title><p>In an attempt to uncover novel regulators of MuSC activity, we decided to take advantage of the atlas of newly discovered lncRNAs, which we previously identified as expressed in proliferating muscle cells (<xref ref-type="bibr" rid="bib5">Ballarino et al., 2015</xref>). Among them, we focused on Lnc-Rewind, which is a lncRNA enriched in proliferating myoblasts and overlapping <italic>pre-Mirlet7c-2</italic> (<italic>mmu-let7c-2</italic>) and <italic>pre-Mirlet7b</italic> (<italic>mmu-let7b</italic>) genomic loci (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). An evolutionary conservation analysis performed by examining FANTOM5 datasets (<xref ref-type="bibr" rid="bib40">Noguchi et al., 2017</xref>) revealed the existence of a conserved transcriptional start site (TSS) localized in the human (hs_Lnc-Rewind) syntenic locus (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). This region exhibits an overall ~46% of (exonic and intronic) sequence identity (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>), which is relatively high for lncRNAs. Moreover, RNA-seq (<xref ref-type="bibr" rid="bib31">Legnini et al., 2017</xref>; <xref ref-type="fig" rid="fig1">Figure 1B</xref>) and semiquantitative (sq)RT-PCR analyses (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>) confirmed that, in proliferating human myoblasts, this region is actively transcribed. To note, the distribution of the read coverage in both mouse and human revealed the existence of spliced and unspliced Lnc-Rewind isoforms originating from the two loci (<xref ref-type="fig" rid="fig1">Figure 1A,B</xref>).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Lnc-Rewind is a conserved chromatin-associated lncRNA expressed in satellite cells.</title><p>(<bold>A</bold>) UCSC visualization showing the chromosome position and the genomic coordinates of Lnc-Rewind (red shade) in the mm9 mouse genome. Mmu_Lnc-Rewind reads coverage and quantification (FPKM) from RNA-Seq experiments performed in proliferating C<sub>2</sub>C<sub>12</sub> cells (<xref ref-type="bibr" rid="bib5">Ballarino et al., 2015</xref>; GSE94498) are shown. (<bold>B</bold>) UCSC visualization showing the chromosome position and the genomic coordinates of hs_Lnc-Rewind (red shade) in the hg19 human genome. Hs_Lnc-Rewind reads coverage and quantification (FPKM) from RNA-Seq experiments performed in proliferating myoblasts (<xref ref-type="bibr" rid="bib31">Legnini et al., 2017</xref>; GSE70389) are shown together with the genomic structure of the human locus (magnified box). (<bold>C</bold>) Relative Lnc-Rewind expression assessed by quantitative RT-PCR (qRT-PCR) in C<sub>2</sub>C<sub>12</sub> myoblast (C<sub>2</sub>C<sub>12</sub>) and MuSC-derived myoblasts (referred as MuSCs) maintained in growing (GM) or differentiated (DM) conditions. Data represent the mean <italic>±</italic> SEM from three biological replicates. <italic>Gapdh</italic> RNA was used as a normalization control. (<bold>D</bold>) Semiquantitative RT-PCR (sqRT-PCR) analysis of spliced and unspliced Lnc-Rewind isoforms in cytoplasmic (Cyt) and nuclear (Nuc) fractions from proliferating C<sub>2</sub>C<sub>12</sub> and MuSC-derived myoblasts. The quality of fractionation was tested with mature (<italic>Gapdh</italic>) and precursor (<italic>pre-Gapdh</italic>) RNAs. –rt represents the negative control. (<bold>E</bold>) RNA-FISH analysis for Lnc-Rewind RNA (red) in proliferating MuSC-derived myoblasts. Autofluorescence (grey) is shown with false colour to visualize the cell body. (<bold>F</bold>) Digital magnification and 3D visualization of the square insert of (<bold>E</bold>). Asterisks indicate the Lnc-Rewind RNA signals inside the nuclear volume. DAPI, 4’,6-diamidino-2-phenylindole (blue). Data information: *p&lt;0.05, unpaired Student’s t-test.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig1">Figure 1</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-54782-fig1-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-54782-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Lnc-Rewind is a conserved chromatin-associated lncRNA expressed in satellite cells.</title><p>(<bold>A</bold>) Table represents the values obtained by analysing the local sequence alignment between the human and murine Lnc-Rewind transcripts. Data were produced by using the implementation of the Smith–Waterman algorithm available at <ext-link ext-link-type="uri" xlink:href="http://www.ebi.ac.uk/Tools/psa/emboss_water/">http://www.ebi.ac.uk/Tools/psa/emboss_water/</ext-link>. (<bold>B</bold>) Semiquantitative RT-PCR (sqRT-PCR) quantification of the human hs_Lnc-Rewind transcript in proliferating (GM) myoblasts from a healthy donor. Mature Gapdh was used as endogenous control. (<bold>C</bold>) FACS plot showing MuSC isolation strategy from WT mice. MuSCs are isolated, among the lineage (CD45/CD31/Ter119) negative cells, as α7integrin+/Sca1− cells (magenta box) (left and middle panels). The right plot shows the check purity of sorted MuSCs. (<bold>D</bold>) qRT-PCR quantification of <italic>Myog</italic> and <italic>Mck</italic> in C<sub>2</sub>C<sub>12</sub> and MuSC-derived myoblasts in growth (GM) and differentiated (DM) conditions. Data represent the mean ± SEM of three biological replicates and were normalized on <italic>Gapdh</italic> mRNA. (<bold>E</bold>) sqRT-PCR quantification of Lnc-Rewind, using different primers, in cytoplasmic (Cyt) and nuclear (Nuc) fractions from proliferating C<sub>2</sub>C<sub>12</sub> and MuSC-derived myoblasts. The quality of fractionation was tested with mature (<italic>Gapdh</italic>) and precursor (<italic>pre-Gapdh</italic>) RNAs. –rt represents the negative control (<bold>F</bold>) Representative 60X confocal images of MuSC-derived myoblasts cell cultures hybridized with probes set specific for Lnc-Rewind (upper panels) and for a human mRNA (dlc1), as negative control (neg ctrl) (bottom panels). Autofluorescence (gray) is shown with false colour to visualize the cell body. DAPI, 4’,6-diamidino-2-phenylindole (blue); scale bar: 25 μm. (<bold>G</bold>) Representative 60× confocal images of C<sub>2</sub>C<sub>12</sub> cell cultures hybridized with probes set specific for Lnc-Rewind (upper panels) and for a human mRNA (dlc1), as negative control (neg ctrl) (bottom panels). Autofluorescence (grey) is shown with false colour to visualize the cell body. DAPI, 4’,6-diamidino-2-phenylindole (blue); scale bar: 25 μm. Data information: *p&lt;0.05, unpaired Student’s t-test.</p><p><supplementary-material id="fig1s1sdata1"><label>Figure 1—figure supplement 1—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-54782-fig1-figsupp1-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-54782-fig1-figsupp1-v2.tif"/></fig></fig-group><p>To pinpoint possible roles of the murine transcript in muscle cells, we first assessed Lnc-Rewind expression and subcellular localization in both C<sub>2</sub>C<sub>12</sub> and Fluorescence-activated cell sorting (FACS) isolated MuSC (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C</xref>) grown under proliferative (hereafter referred to as MuSC-derived myoblasts) and differentiating conditions. Proper myogenic differentiation was confirmed by the expression of late muscle-specific genes such as myogenin (<italic>Myog</italic>) and muscle creatin kinase (<italic>Mck</italic>) (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1D</xref>). Quantitative qRT-PCR analysis revealed that Lnc-Rewind expression is high in proliferating (GM) C<sub>2</sub>C<sub>12</sub> and MuSC-derived myoblasts and significantly decreased in fully differentiated (DM) cells (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). Subcellular fractionation of cytoplasmic (Cyt) and nuclear (Nuc) fractions showed that both spliced and unspliced isoforms localizes in the nuclear compartment (<xref ref-type="fig" rid="fig1">Figure 1D</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1E</xref>). Accordingly, RNA fluorescence in situ hybridization (FISH) experiments performed in both MuSC-derived myoblasts (<xref ref-type="fig" rid="fig1">Figure 1E,F</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1F</xref>) and C<sub>2</sub>C<sub>12</sub> cells (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1G</xref>) confirmed the nuclear localization of Lnc-Rewind and further revealed its specific enrichment to discrete chromatin foci. Overall, these results point towards a role for Lnc-Rewind in chromatin-based processes and suggest its possible involvement in the epigenetic regulation of MuSC homeostasis.</p></sec><sec id="s2-2"><title>Lnc-Rewind regulates muscle system processes and MuSC expansion</title><p>To gain insights into the functional role of Lnc-Rewind and to identify the molecular pathways involved in the regulation of muscle stem cells, we performed a global transcriptional profiling on MuSC-derived myoblasts treated with either a mix of three different LNA GapmeRs against Lnc-Rewind (GAP-REW) or the scramble control (GAP-SCR) (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>, upper panel). Under these conditions, we obtained ~70% reduction of Lnc-Rewind expression (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>, lower panel), which led to the identification of a set of 1088 differentially expressed genes (DEGs) (p&lt;0.05, GAP-SCR vs GAP-REW). Of these, 332 were upregulated and 756 downregulated in GAP-REW as compared to the GAP-SCR condition (<xref ref-type="fig" rid="fig2">Figure 2A</xref>, <xref ref-type="supplementary-material" rid="fig2sdata1">Figure 2—source data 1</xref>). A principal component analysis (PCA) performed on the DEG datasets revealed that the GAP-SCR and GAP-REW experimental groups displayed a clear different pattern of gene expression since they occupy different regions of the PCA plot (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref>). The DEG list was then subjected to Gene Ontology (GO) term enrichment analysis (Biological process) to define functional clusters. It emerged that DEGs were mostly associated with muscle cell physiology (skeletal muscle contraction, p-value=4.23E-6) (<xref ref-type="fig" rid="fig2">Figure 2B</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C</xref>). Of note, the analysis of Lnc-Rewind generated miRNAs (<italic>Mirlet7b</italic> and <italic>Mirlet7c-2</italic>) revealed that, although the lncRNA depletion results on their concomitant downregulation (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1D</xref>), none of the upregulated transcripts that are also putative <italic>Mirlet7b</italic> and <italic>Mirlet7c-2</italic> targets (~1% of the upregulated genes) (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1E</xref>), belong to any of the GO enriched categories. This result emphasizes a specific and miRNA-independent role for Lnc-Rewind. Both ‘muscle system process’ (p-value=3.45E-7) and ‘striated muscle contraction’ (p-value=4.63E-7) were the most significantly enriched GO terms (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C</xref>). Of note, genes encoding for different proteins involved in muscle contraction, such as myosins (i.e. <italic>Myh8</italic>, <italic>Myl1, Myh3</italic>) and troponins (i.e. <italic>Tnnt2</italic>, <italic>Tnnt1</italic>) (<xref ref-type="fig" rid="fig2">Figure 2C</xref>), were downregulated. Accordingly, Lnc-Rewind-depleted cells express lower levels of MyHC protein (<xref ref-type="fig" rid="fig2">Figure 2D</xref>). Moreover, morphological evaluation highlighted a decreased number of MuSC-derived myoblasts after Lnc-Rewind depletion (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1F</xref>), suggesting a primary defect in MuSC proliferation. This led us to hypothesize that the defects in myogenic capacity (<xref ref-type="fig" rid="fig2">Figure 2C,D</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1F</xref>) might result by a decreased cell density that normally leads to a lower rate of myogenic differentiation. In line with this hypothesis, EdU incorporation experiments revealed a striking reduction of proliferating MuSC-derived myoblasts upon depletion of Lnc-Rewind (<xref ref-type="fig" rid="fig2">Figure 2E</xref>). Accordingly, the <italic>Ccnd3</italic> gene encoding for Cyclin D3, a cyclin specifically involved in promoting transition from G1 to S phase, was significantly downregulated in Lnc-Rewind-depleted cells at both transcript (<xref ref-type="supplementary-material" rid="fig2sdata1">Figure 2—source data 1</xref>) and protein levels (<xref ref-type="fig" rid="fig2">Figure 2D</xref>). In further support of this, MuSCs on single myofibres cultured for 96 hr gave rise to a decreased percentage of proliferating (Pax7<sup>+</sup>/Ki67<sup>+</sup>) progeny upon Lnc-Rewind downregulation (<xref ref-type="fig" rid="fig2">Figure 2F</xref>). Moreover, quantification of the number of Pax7<sup>+</sup>-derived clusters (composed of more than two nuclei), pairs (composed of two nuclei), or single MuSCs within each myofibre revealed a reduction of activated pairs and clusters upon Lnc-Rewind depletion (<xref ref-type="fig" rid="fig2">Figure 2G</xref>), suggesting a role for the lncRNA in sustaining MuSC activation and expansion.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Lnc-Rewind regulates muscle system processes and MuSC expansion.</title><p>(<bold>A</bold>) Heatmap representing hierarchical clustering performed on the final list of genes differentially expressed in MuSC-derived myoblasts upon Lnc-Rewind depletion (p-value threshold&lt;0.05; see also <xref ref-type="supplementary-material" rid="fig2sdata1">Figure 2—source data 1</xref>). The analysis was performed using the Heatmapper webserver tool (<xref ref-type="bibr" rid="bib4">Babicki et al., 2016</xref>). For each gene, expression levels are expressed as Z-score values. (<bold>B</bold>) Gene Ontology (GO) enrichment analysis performed by GORILLA (<xref ref-type="bibr" rid="bib18">Eden et al., 2009</xref>) in Biological process for genes differentially expressed upon Lnc-Rewind depletion in MuSC-derived myoblasts. (<bold>C</bold>) Heatmap representing hierarchical clustering performed on DEGs belonging to the Skeletal Muscle contraction GO category (GO:0003009). The analysis was performed using the Heatmapper webserver tool (<xref ref-type="bibr" rid="bib4">Babicki et al., 2016</xref>). For each gene, expression levels are expressed as Z-score values. (<bold>D</bold>) Western blot analysis performed on protein extracts from MuSC-derived myoblasts treated with GAP-SCR or GAP-REW. GAPDH protein was used as endogenous control. (<bold>E</bold>) Representative images of MuSC-derived myoblasts treated with GAP-SCR and GAP-REW and incubated with EdU (red). Nuclei were visualized with DAPI (blue). Histogram shows the percentage of EdU-positive cells on the total of DAPI-positive cells. Data are graphed as mean ± SEM; n = 6 mice. (<bold>F</bold>) Representative images of single muscle fibres from WT mice treated with GAP-SCR or GAP-REW and stained for Pax7 (red) and Ki67 (green). Nuclei were visualized with DAPI (blue); histogram shows the percentage of Pax7<sup>+</sup>/Ki67<sup>−</sup> cells on the total of Pax7<sup>+</sup>/Ki67<sup>+</sup> cells per cluster. Data represent the mean ± SEM of 40 clusters per condition; n = 5 mice. (<bold>G</bold>) Representative images of single muscle fibres from WT mice treated with GAP-SCR or GAP-REW and incubated for 24 hr with EdU (red). Nuclei were visualized with DAPI (blue); left histogram shows the number of Pax7<sup>+</sup> cells per fibre (50 fibres per condition; n = 5 mice). Right histograms represent the mean of clusters (nuclei [n], n &gt; 2), pairs (n = 2), and single cells Pax7<sup>+</sup> (n = 1) per fibre. Data represent the mean ± SEM of 80 fibres per condition; n = 5 mice. Data information: *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, unpaired Student’s t-test.</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>List of the differentially expressed genes (DEGs) between GAP-SCR and GAP-REW transfected MuSCs.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-54782-fig2-data1-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig2sdata2"><label>Figure 2—source data 2.</label><caption><title>Source data for <xref ref-type="fig" rid="fig2">Figure 2</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-54782-fig2-data2-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-54782-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Lnc-Rewind regulates muscle system processes and MuSC expansion.</title><p>(<bold>A</bold>) Upper part: Experimental timeline used for the transfection of MuSC-derived myoblasts with GAP-SCR or GAP-REW. Lower part: qRT-PCR quantification of Lnc-Rewind spliced and unspliced transcript in MuSC-derived myoblasts treated with GAP-SCR or GAP-REW. Data were normalized to <italic>Gapdh</italic> mRNA and expressed as fold change of the mean ± SEM of four biological replicates. (<bold>B</bold>) PCA analysis of DEGs upon Lnc-Rewind depletion. GAP-REW and GAP-SCR RNA-seq replicates are shown, respectively, as red and black dots. PC1 and PC2 represent the top two dimensions of the PCA which account, respectively, for 65% and 25% of the total variability. (<bold>C</bold>) Table shows the GO terms, their description, the p-value, the false discovery rate (in decreasing order of statistical significance), and the enrichment of the different categories listed in the diagram of <xref ref-type="fig" rid="fig2">Figure 2B</xref>. (<bold>D</bold>) qRT-PCR quantification of <italic>mmu-Mirlet7-b</italic> and <italic>mmu-Mirlet7-c-2</italic> miRNAs in GAP-SCR- or GAP-REW-treated MuSC-derived myoblasts. Data were normalized to <italic>Gapdh</italic> mRNA and expressed as fold change of the mean ± SEM of three biological replicates. (<bold>E</bold>) Target prediction analyses performed by crossing the genes upregulated upon Lnc-Rewind depletion with the <italic>mmu-Mirlet7b/c2-3p</italic> (yellow) and <italic>mmu-Mirlet7b/c2-5p</italic> (blue) predicted target genes. Predictions were obtained from Targetscan database (<xref ref-type="bibr" rid="bib2">Agarwal et al., 2015</xref>). (<bold>F</bold>) Representative images (left) and cells number quantification (right) of MuSC-derived myoblasts treated with GAP-SCR or GAP-REW. Data represent the mean percentage ± SEM of three biological replicates. Data information: *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, unpaired Student’s t-test.</p><p><supplementary-material id="fig2s1sdata1"><label>Figure 2—figure supplement 1—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-54782-fig2-figsupp1-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-54782-fig2-figsupp1-v2.tif"/></fig></fig-group></sec><sec id="s2-3"><title>Lnc-Rewind and <italic>Wnt7b</italic> genes display opposite pattern of expression and a functional interplay</title><p>Together with the muscle-specific genes, the ‘regulation of Wnt signalling pathway’ GO term caught our attention as it was represented by a significant subset of trancripts (p-value=5.44E-4, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C</xref>). Among them, we found <italic>Wnt7b</italic>, which expression was found upregulated at both transcript and protein levels (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A</xref> and <xref ref-type="supplementary-material" rid="fig2sdata1">Figure 2—source data 1</xref>), suggesting a role for Lnc-Rewind as a repressor of <italic>Wnt7b</italic> expression. Intriguingly, <italic>Wnt7b</italic> transcriptional locus localizes only 100 kb upstream Lnc-Rewind gene (<xref ref-type="fig" rid="fig3">Figure 3A</xref>).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Lnc-Rewind and <italic>Wnt7b</italic> genes display opposite pattern of expression and a functional interplay.</title><p>(<bold>A</bold>) Schematic UCSC visualization showing the Lnc-Rewind chromosome position and its neighbouring genes. (<bold>B</bold>) TSS usage analyses of <italic>Wnt7b</italic>, Lnc-Rewind, <italic>Atxn10</italic>, and <italic>Cdpf1</italic> performed by using FANTOM5 (Phases 1 and 2) CAGE datasets. Each bar represents the Relative Logarithmic Expression (RLE) of the tag per million (TPM) values of the TSS of each gene in one sample (1196 samples). The order of the samples is the same in each of the histograms and shown in <xref ref-type="supplementary-material" rid="fig3sdata1">Figure 3—source data 1</xref>. R value represents the Spearman’s rank correlation coefficient between Lnc-Rewind and <italic>Wnt7b</italic> expression, and the p-value was calculated using the Spearman’s rank correlation test. (<bold>C</bold>) qRT-PCR quantification of Lnc-Rewind neighbouring genes in GAP-SCR <italic>versus</italic> GAP-REW treated. MuSCs-derived myoblasts. Data were normalized to <italic>Gapdh</italic> mRNA and represent the average ± SEM from four biological replicates. (<bold>D</bold>) Representative images of MuSC-derived myoblasts treated with GAP-SCR/si-SCR, GAP-REW, and GAP-REW/si-Wnt7b and incubated with EdU (red). Nuclei were visualized with DAPI, 4′,6-diamidino-2-phenylindole (blue). Histogram shows the percentage of EdU-positive cells on the total of DAPI-positive cells. Data are graphed as mean ± SEM; n = 5 mice. (<bold>E</bold>) Representative images of single muscle fibres treated with GAP-SCR/si-SCR, GAP-REW, and GAP-REW/si-Wnt7b from WT mice after 96 hr in culture, stained for Pax7 (red) and Ki67 (green). Nuclei were visualized with DAPI, 4′,6-diamidino-2-phenylindole (blue). Histogram (upper panel) shows the number of Pax7<sup>+</sup> cells per fibre. Histograms (lower panel) represent the mean of the number of clusters (nuclei [n]: n &gt; 2), pairs (n = 2), and single cells Pax7<sup>+</sup> (n = 1) per fibre. Data represent the mean ± SEM; n = 5 mice. Data information: (<bold>C</bold>): *p&lt;0.05, paired Student’s t-test. 3D and 3E: *p&lt;0.05, **p&lt;0.01, ***&lt;0.001, one-way Anova with Tukey’s multiple comparison test.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>5'CAGE TSS expression profile of Wnt7b, Lnc-Rewind, Atxn10 and Cdpf1 genes.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-54782-fig3-data1-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig3sdata2"><label>Figure 3—source data 2.</label><caption><title>Source data for <xref ref-type="fig" rid="fig3">Figure 3</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-54782-fig3-data2-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-54782-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Lnc-Rewind and <italic>Wnt7b</italic> genes display opposite pattern of expression and a functional interplay.</title><p>(<bold>A</bold>) qRT-PCR (left panel) and Western blot (right panel) analyses performed on extracts from MuSC-derived myoblasts, treated with GAP-SCR or GAP-REW.<italic> Gapdh</italic> mRNA and protein were used as endogenous control. Error bars represent the mean ± SEM of four biological replicates. (<bold>B</bold>) TPM (transcripts per million) values of Lnc-Rewind neighbouring genes obtained from the RNA-seq analyses performed in GAP-SCR- versus GAP-REW-treated MuSC-derived myoblasts. TPM values are presented as average ± SD of four biological replicates. (<bold>C</bold>) qRT-PCR quantification of Lnc-Rewind and <italic>Wnt7b</italic> in GAPSCR/si-SCR, GAP-REW, and GAP-REW/si-Wnt7b conditions. Data were normalized to <italic>Gapdh</italic> mRNA and represent the mean ± SEM of four biological replicates. Data information: (<bold>A</bold>) **p&lt;0.01, unpaired Student’s t-test. (<bold>B</bold>) *p&lt;0.05, **p&lt;0.01, paired Student’s t-test. (<bold>C</bold>) *p&lt;0.05, **p&lt;0.01, one-way Anova with Tukey’s multiple comparison test.</p><p><supplementary-material id="fig3s1sdata1"><label>Figure 3—figure supplement 1—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-54782-fig3-figsupp1-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-54782-fig3-figsupp1-v2.tif"/></fig></fig-group><p>The genomic proximity between Lnc-Rewind<italic>/Wnt7b</italic> loci, together with their anti-correlated expression in muscle cells and the lncRNA chromatin enrichment (<xref ref-type="fig" rid="fig1">Figure 1D,E</xref>), led us to hypothesize that Lnc-Rewind might have a direct, in cis-regulatory role on <italic>Wnt7b</italic> transcription. A first clue in favour of such hypothesis came from FANTOM5 Cap Analysis Gene Expression (CAGE) profiles of mouse samples, available on ZENBU genome browser (<xref ref-type="bibr" rid="bib40">Noguchi et al., 2017</xref>). Indeed, the inspection of the TSS usage among all the available murine samples (n = 1196, <xref ref-type="supplementary-material" rid="fig3sdata1">Figure 3—source data 1</xref>) revealed a distinctive anti-correlated expression between Lnc-Rewind and <italic>Wnt7b</italic> transcripts (<xref ref-type="fig" rid="fig3">Figure 3B</xref>, left panels). In contrast, the other Lnc-Rewind-neighbouring genes, such as <italic>Cdpf1</italic> and <italic>Atxn10</italic>, displayed no specific expression correlation (<xref ref-type="fig" rid="fig3">Figure 3B</xref>, right panels). Of note, <italic>Wnt7b</italic> was the only gene that was significantly upregulated upon the lncRNA depletion with a concomitant increase in WNT7b protein levels (<xref ref-type="fig" rid="fig3">Figure 3C</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A, B</xref>).</p><p>To uniquely link the defects in MuSC activation/proliferation induced by Lnc-Rewind depletion (<xref ref-type="fig" rid="fig2">Figure 2E–G</xref>) to the aberrant induction of <italic>Wnt7b</italic> expression, we performed a rescue experiment. To this end, in a context where the upregulation of <italic>Wnt7b</italic> was triggered by Lnc-Rewind depletion, we restored its expression to physiological levels by si-<italic>Wnt7b</italic>-mediated knockdown (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1C</xref>). Of note, rescuing <italic>Wnt7b</italic> repression promoted an increase in the percentage of proliferating MuSC-derived myoblasts towards control levels (<xref ref-type="fig" rid="fig3">Figure 3D</xref>). Similarly, restoration of <italic>Wnt7b</italic> repression on single myofibres was sufficient to restore the capacity of the associated MuSCs to properly activate and proliferate ex vivo (<xref ref-type="fig" rid="fig3">Figure 3E</xref>), as assessed by the quantification of the number of Pax7<sup>+</sup> MuSCs and the percentage of single MuSCs, and derived clusters and pairs, within each myofibre (<xref ref-type="fig" rid="fig3">Figure 3E</xref>). Together, these findings clearly candidate the Lnc-Rewind transcript as a regulator of <italic>Wnt7b</italic> repression in muscle stem cells and prompted us towards the study of the underlying mechanism by which this regulation occurs.</p></sec><sec id="s2-4"><title>Lnc-Rewind directly interacts with the methyltransferase G9a and mediates specific in cis repression of <italic>Wnt7b</italic> in MuSCs</title><p>The above results suggest that Lnc-Rewind exerts a repressive role on <italic>Wnt7b</italic> gene expression. Several works accumulated so far indicate that most of the <italic>cis</italic>-acting chromatin-associated lncRNA function occurs by recruiting and guiding chromatin modifiers to target genes (<xref ref-type="bibr" rid="bib8">Batista and Chang, 2013</xref>; <xref ref-type="bibr" rid="bib24">Guttman and Rinn, 2012</xref>; <xref ref-type="bibr" rid="bib27">Khalil et al., 2009</xref>; <xref ref-type="bibr" rid="bib47">Rinn and Chang, 2012</xref>). In light of our data showing a negative correlation of <italic>Wnt7b</italic> expression by Lnc-Rewind, we focused our attention on the two most known repressive lysine methyltransferases, EZH2 and G9a, which catalyse the deposition of H3K27me3 and H3K9me1/2 on target genes, respectively (<xref ref-type="bibr" rid="bib37">Mozzetta et al., 2015</xref>). Both EZH2 (<xref ref-type="bibr" rid="bib11">Caretti et al., 2004</xref>) and G9a (<xref ref-type="bibr" rid="bib32">Ling et al., 2012</xref>) are mostly expressed in proliferating MuSCs and become downregulated during muscle differentiation (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>), similarly to Lnc-Rewind (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). Moreover, both EZH2 (<xref ref-type="bibr" rid="bib46">Rinn et al., 2007</xref>; <xref ref-type="bibr" rid="bib60">Zhao et al., 2008</xref>) and G9a (<xref ref-type="bibr" rid="bib39">Nagano et al., 2008</xref>; <xref ref-type="bibr" rid="bib43">Pandey et al., 2008</xref>) have been previously reported to be recruited to specific genomic loci through the interaction with different lncRNAs. Thus, we hypothesized that in proliferating myoblasts Lnc-Rewind might interact with EZH2 and/or G9a repressive complexes to tether them on <italic>Wnt7b</italic> genomic locus. Therefore, we performed RNA immunoprecipitation (RIP) analysis in proliferating C<sub>2</sub>C<sub>12</sub> cells using antibodies against G9a and EZH2. We observed that, although both G9a and EZH2 were successfully immunoprecipitated (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B</xref>, upper panel), Lnc-Rewind transcript was efficiently retrieved only in the G9a native RIP, while it was almost undetectable in EZH2 IP (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B</xref>, lower panel). To note, the levels of RNA obtained in the specific IP fraction were similar to the ones of the <italic>Kcnq1ot1</italic> lncRNA, which was previously demonstrated to be physically associated with both G9a and Ezh2 proteins (<xref ref-type="bibr" rid="bib43">Pandey et al., 2008</xref>). The specificity of Lnc-Rewind and G9a interaction was strengthened by the use of two reciprocal strategies (<xref ref-type="fig" rid="fig4">Figure 4</xref>). On the one hand, the G9a-crosslinked immunoprecipitation (CLIP) assay (<xref ref-type="fig" rid="fig4">Figure 4A</xref>) revealed the presence of Lnc-Rewind in the G9a immunoprecipitated samples. As for RIP, also in this case, Lnc-Rewind RNA-specific enrichment was comparable to the <italic>Kcnq1ot1-</italic>positive control. As a further validation, endogenous Lnc-Rewind RNA pulldown (<xref ref-type="fig" rid="fig4">Figure 4B</xref>) revealed the presence of G9a in the lncRNA-precipitated fraction. This evidence confirmed the direct interaction between these two partners and led us to hypothesize that Lnc-Rewind might exert its repressive function on the <italic>Wnt7b</italic> locus through G9a. In support of this, depletion of G9a by siRNA-mediated knockdown in MuSC-derived myoblasts induced <italic>Wnt7b</italic> upregulation (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). To test whether Lnc-Rewind and G9a binds the <italic>Wnt7b</italic> locus in vivo, we applied RNA-DNA-FISH (<xref ref-type="fig" rid="fig4">Figure 4D</xref>) and a chromatin immunoprecipitation (ChIP) assay (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1C</xref>), respectively. In agreement with our hypothesis, we found an overlap between Lnc-Rewind (RNA) and <italic>Wnt7b</italic> (DNA) localization (<xref ref-type="fig" rid="fig4">Figure 4D</xref>) and an intriguing enrichment of the methyltransferase in the <italic>Wnt7b</italic> upstream regions (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1C</xref>). Consistent with a role of Lnc-Rewind in the G9a-mediated epigenetic repression of <italic>Wnt7b</italic>, quantification of the H3K9me2 mark on the G9a-occupied genomic regions (<xref ref-type="fig" rid="fig4">Figure 4E</xref>, upper panel) showed that H3K9me2 deposition decreased upon Lnc-Rewind knockdown, compared to the GAP-SCR control (<xref ref-type="fig" rid="fig4">Figure 4E</xref>, lower panel). Moreover, a combined Lnc-Rewind (RNA)/<italic>Wnt7b</italic> (DNA) FISH/G9a (PROTEIN) immunostaining approach showed the colocalization of both G9a and Lnc-Rewind on <italic>Wnt7b</italic> genomic locus (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). Taken together, these results support a mechanism of action through which in MuSC Lnc-Rewind represses <italic>Wnt7b</italic> gene transcription by mediating the specific G9a-dependent H3K9me2 deposition on its locus (<xref ref-type="fig" rid="fig5">Figure 5B</xref>).</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Lnc-Rewind directly interacts with the methyltransferase G9a and mediates specific in cis repression of <italic>Wnt7b</italic>.</title><p>(<bold>A</bold>) G9a crosslinked RNA immunoprecipitation assay (CLIP) performed on nuclear extracts from C<sub>2</sub>C<sub>12</sub> proliferating myoblasts. Western blot analysis of G9a (left panel) and qRT-PCR quantification of Lnc-Rewind recovery (right panel) expressed as input percentage (Input %) are shown. EZH2 protein and <italic>Gapdh</italic> RNA serve as negative controls; <italic>Kcnq1ot</italic> RNA is used as positive control. Data represent mean ± SEM of three biological replicates. (<bold>B</bold>) Lnc-Rewind RNA pulldown assay performed on nuclear extracts from C<sub>2</sub>C<sub>12</sub> proliferating myoblasts. qRT-PCR quantification of Lnc-Rewind recovery (left panel) and Western blot analysis of G9a (right panel) are shown. <italic>Gapdh</italic> RNA and EZH2 protein serve as negative controls. Data represent mean ± SEM of three biological replicates. (<bold>C</bold>) qRT-PCR quantification of <italic>G9a</italic> and <italic>Wnt7b</italic> in MuSC-derived myoblasts treated with si-SCR or si-G9a. Data were normalized to <italic>Gapdh</italic> mRNA and represent the mean ± SEM of three biological replicates. (<bold>D</bold>) RNA/DNA-FISH experiments performed in proliferating MuSC-derived myoblasts showing the Lnc-Rewind RNA (red) and a DNA control (CTRL) region (green) (<bold>a</bold>) or the <italic>Wnt7b</italic> locus (green) (<bold>b</bold>). Inserts in (<bold>c</bold>) show single fluorescent channels for Lnc-Rewind and <italic>Wnt7b</italic> signals labelled by asterisks. Blue lines indicate the edges of the nuclei. DAPI, 4′,6‐diamidino‐2‐phenylindole (blue). Histogram reports the mean percentage ± SD of Lnc-Rewind signals colocalizing with <italic>Wnt7b</italic> locus or with the control region from three biological replicates. The extended list of the DNA and RNA probes used is listed in Key resources table. (<bold>E</bold>) Zoom-in into the genomic region upstream the <italic>Wnt7b</italic> TSS (upper panel). ChIP amplicons used to test the H3K9me2 enrichments are shown in green. Histogram shows the levels of H3K9me2 as analysed by ChIP experiments performed in MuSC-derived myoblasts upon GAP-SCR or GAP-REW transfection (lower panel). The H3K9me2 enrichment is represented as input percentage (Input %). <italic>Ube2b</italic> and <italic>R15</italic> genomic regions were used as negative and positive controls, respectively. The graph shows the mean ± SEM of six independent experiments. Data information: (<bold>B</bold>) and (<bold>E</bold>): *p&lt;0.05, paired Student’s t-test. (<bold>C</bold>) and (<bold>D</bold>): **p&lt;0.01, ***p&lt;0.001, unpaired Student’s t-test.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig4">Figure 4</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-54782-fig4-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-54782-fig4-v2.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Lnc-Rewind directly interacts with the methyltransferase G9a and mediates specific in cis repression of <italic>Wnt7b</italic>.</title><p>(<bold>A</bold>) Western blot analysis performed on protein extracted from WT MuSC-derived myoblasts cultured in growth (GM) and differentiated (DM) conditions. GAPDH protein was used as endogenous control. (<bold>B</bold>) G9a and EZH2 native RNA immunoprecipitation (RIP) performed on nuclear extracts of C<sub>2</sub>C<sub>12</sub> proliferating myoblasts. Data represent mean ± SEM of four biological replicates. Western blot analysis of G9a and EZH2 (upper panel) and qRT-PCR quantification of Lnc-Rewind recovery (lower panel) are shown. EZH2 protein serves as negative control. <italic>Gapdh</italic> and <italic>Kcnq1ot1</italic> RNAs serve, respectively, as negative and positive controls. (<bold>C</bold>) Chromatin immunoprecipitation (ChIP) of G9a performed in C<sub>2</sub>C<sub>12</sub> proliferating myoblasts; enrichment was calculated as (IP-IgG)/Input and represented as input percentage (Input %). <italic>Gapdh</italic> genomic region was used as negative control, while <italic>Myog</italic> and <italic>R15</italic> genomic regions were used as positive controls. The graph shows the mean ± SEM of three biological replicates. Data information: *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, unpaired Student’s t-test.</p><p><supplementary-material id="fig4s1sdata1"><label>Figure 4—figure supplement 1—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-54782-fig4-figsupp1-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-54782-fig4-figsupp1-v2.tif"/></fig></fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Lnc-Rewind and G9a colocalize on <italic>Wnt7b</italic> gene locus.</title><p>(<bold>A</bold>) Top panel: RNA/DNA-FISH combined with immunofluorescence performed on MuSC-derived myoblasts; Lnc-Rewind RNA (red), <italic>Wnt7b</italic> DNA locus (green), and G9a protein (grey) are shown. Bottom panel: Isosurface rendering of nuclear sections is indicated by the yellow dashed lines. The overlapping regions between Lnc-Rewind (RNA) and <italic>Wnt7b</italic> (DNA) locus (left) and among Lnc-Rewind, <italic>Wnt7b</italic> locus, and G9a (right) are indicated by the white asterisks inside the nuclear volume. (<bold>B</bold>) Proposed model for the functional interplay between Lnc-Rewind and G9a on <italic>Wnt7b</italic> gene locus. Representation of mmu_Lnc-Rewind mode of action in muscle cells. In proliferating myoblasts, the Lnc-Rewind transcript is expressed, recruits the silencing methyltransferase G9a on the locus that represses <italic>Wnt7b</italic> transcription.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-54782-fig5-v2.tif"/></fig></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Wnt signalling represents one of the pathways that has a major role in myogenesis as it is essential for proper MuSC self-renewal and differentiation (<xref ref-type="bibr" rid="bib55">von Maltzahn et al., 2012</xref>). A correct timing of Wnt signalling activation is crucial to obtain proper tissue repair, and its aberrant activity causes a wide range of pathologies (<xref ref-type="bibr" rid="bib41">Nusse and Clevers, 2017</xref>). Thus, it is not surprising that Wnt pathway is under a strict positive and negative multi-layered regulation. Recent studies show that lncRNAs can modulate Wnt pathway by affecting gene expression through different mechanisms, from transcriptional to post-transcriptional level (<xref ref-type="bibr" rid="bib42">Ong et al., 2017</xref>; <xref ref-type="bibr" rid="bib52">Shen et al., 2017</xref>; <xref ref-type="bibr" rid="bib59">Zarkou et al., 2018</xref>) For example, lncRNAs were found interacting with transcription factors (<xref ref-type="bibr" rid="bib16">Desideri et al., 2020</xref>) and chromatin modifiers (<xref ref-type="bibr" rid="bib25">Hu et al., 2015</xref>) altering Wnt signalling pathway in different tissues and in cancer. In this study, we discovered that lncRNAs-mediated regulation plays a role in modulating Wnt pathway in muscle stem cells. Taking advantage of a newly discovered atlas of not annotated muscle-specific lncRNAs (<xref ref-type="bibr" rid="bib5">Ballarino et al., 2015</xref>), we decided to focus our attention on Lnc-Rewind for the following reasons: (1) an orthologue transcript, hs_Lnc-Rewind, with high level of sequence identity is expressed by human myoblasts (<xref ref-type="fig" rid="fig1">Figure 1B</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A,B</xref>); (2) Lnc-Rewind is associated and retained to chromatin (<xref ref-type="fig" rid="fig1">Figure 1D–F</xref>); (3) it is in genomic proximity to <italic>Wnt7b</italic> locus (<xref ref-type="fig" rid="fig3">Figure 3A</xref>), and (4) its knockdown induces upregulation of <italic>Wnt7b</italic> in MuSC-derived myoblasts (<xref ref-type="fig" rid="fig3">Figure 3C</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A,B</xref>). Interestingly, the read coverage revealed the existence of multiple isoforms that are not fully spliced. The slowness in the splicing process could contribute to the maintenance of Lnc-Rewind at its own site of transcription improving its retention on the chromatin. In line with this, recent evidence indicates that the presence of introns, and their distinct processing, may represent a way to regulate the nuclear localization and function of many lncRNAs (<xref ref-type="bibr" rid="bib23">Guo et al., 2020</xref>; <xref ref-type="bibr" rid="bib63">Zuckerman and Ulitsky, 2019</xref>). These observations led us hypothesize a Lnc-Rewind-mediated in cis repression for <italic>Wnt7b</italic> gene. Of note, by analyzing the expression of surrounding genes within Lnc-Rewind genomic region, <italic>Wnt7b</italic> is the only gene to be significantly upregulated by Lnc-Rewind depletion (<xref ref-type="fig" rid="fig3">Figure 3C</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1B</xref>). Moreover, we show that Lnc-Rewind and <italic>Wnt7b</italic> expressions are anti-correlated in different cell types (<xref ref-type="fig" rid="fig3">Figure 3B</xref>), suggesting that the repressive action of Lnc-Rewind on <italic>Wnt7b</italic> locus could have a more general role, not only in satellite cells.</p><p>It is well-accepted that the majority of the <italic>cis</italic>-acting chromatin-associated lncRNAs function by recruiting and targeting chromatin modifiers to specific genes (<xref ref-type="bibr" rid="bib8">Batista and Chang, 2013</xref>; <xref ref-type="bibr" rid="bib24">Guttman and Rinn, 2012</xref>; <xref ref-type="bibr" rid="bib27">Khalil et al., 2009</xref>; <xref ref-type="bibr" rid="bib47">Rinn and Chang, 2012</xref>). In light of the evidence that Lnc-Rewind promotes <italic>Wnt7b</italic> repression, we decided to investigate the involvement of the two major repressive histone modifiers, EZH2 and G9a, in mediating such Lnc-Rewind-dependent silencing. Notably, by performing both protein- and RNA-centric biochemical approaches (RIP/CLIP and RNA pulldown), we found that only G9a specifically interacts with Lnc-Rewind (<xref ref-type="fig" rid="fig4">Figure 4A, B</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B</xref>). This strongly suggests that the histone H3K9 lysine methyltransferase (KMT) might be specifically tethered on <italic>Wnt7b</italic> genomic locus by Lnc-Rewind to mediate its transcriptional repression. In support of this idea, through H3K9me2 ChIP experiments here we provide evidence that different regions upstream <italic>Wnt7b</italic> locus are enriched in the G9a-deposited histone mark in MuSC-derived myoblasts and that H3K9me2 levels on these regions significantly decrease upon Lnc-Rewind knockdown (<xref ref-type="fig" rid="fig4">Figure 4E</xref>). Moreover, both ChIP (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1C</xref>) and imaging (<xref ref-type="fig" rid="fig4">Figure 4D</xref>) studies confirmed the presence of G9a in close proximity to <italic>Wnt7b</italic> locus. These data, together with the evidence that G9a downregulation is sufficient to induce <italic>Wnt7b</italic> de-repression (<xref ref-type="fig" rid="fig4">Figure 4C</xref>), confirm a direct role for G9a-mediated H3K9 methylation in maintaining the repression of <italic>Wnt7b</italic> in MuSCs.</p><p>A correct timing and magnitude of Wnt signalling activation is essential to maintain functional MuSCs. For instance, it has been shown that low β-catenin activity is fundamental during early phases of muscle regeneration to allow MuSC activation and subsequent differentiation (<xref ref-type="bibr" rid="bib22">Figeac and Zammit, 2015</xref>; <xref ref-type="bibr" rid="bib44">Parisi et al., 2015</xref>). Accordingly, satellite cells isolated from mice with constitutive active Wnt/β-catenin signalling display an early growth arrest and premature differentiation (<xref ref-type="bibr" rid="bib50">Rudolf et al., 2016</xref>). All these data point out that the cell environment, together with the timing and the proper activation of Wnt signalling pathway, is fundamental for muscle homeostasis.</p><p>Although the function of WNT7b has been studied in different cell types and developmental processes (<xref ref-type="bibr" rid="bib14">Chen et al., 2014</xref>; <xref ref-type="bibr" rid="bib56">Wang et al., 2005</xref>), the involvement of this ligand in muscle biology is still rather unexplored. The fact that in MuSCs, <italic>Wnt7b</italic> gene is maintained at very low levels and that it is the latest Wnt ligand induced after muscle injury (<xref ref-type="bibr" rid="bib45">Polesskaya et al., 2003</xref>) suggests the necessity to keep it repressed to allow MuSC expansion. In line with this, here we show that aberrant, cell-autonomous activation of <italic>Wnt7b</italic> expression upon Lnc-Rewind depletion causes defects in MuSC expansion and activation (<xref ref-type="fig" rid="fig2">Figure 2E–G</xref>) that are abolished if the expression of <italic>Wnt7b</italic> is rescued to physiological levels (<xref ref-type="fig" rid="fig3">Figure 3D,E</xref>), emphasizing that Lnc-Rewind-mediated repression of <italic>Wnt7b</italic> is key in ensuring MuSC activity. This is nicely supported by a previous study demonstrating that, in the cytoplasm, a <italic>Wnt7b</italic>/lncRNA circuitry controls the proliferation of C<sub>2</sub>C<sub>12</sub> myoblasts. Specifically, Lu and colleagues demonstrated that the YY1-associated muscle lincRNA (<italic>Yam-1</italic>) inhibits skeletal myogenesis through modulation of <italic>Mir715</italic> expression, which in turn targets <italic>Wnt7b</italic> mRNA (<xref ref-type="bibr" rid="bib33">Lu et al., 2013</xref>). In sum, our results support a mechanism of action through which Lnc-Rewind mediates G9a recruitment on <italic>Wnt7b</italic> locus to silence it through the deposition of the repressive mark H3K9me2 during the proliferation phase of satellite cells (<xref ref-type="fig" rid="fig5">Figure 5B</xref>), thus providing unique insights on the contribution of nuclear-enriched lncRNAs in myogenesis.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th>Reagent type <break/>(species) or <break/>resource</th><th>Designation</th><th>Source or <break/>reference</th><th>Identifiers</th><th colspan="2">Additional <break/>information</th></tr></thead><tbody><tr><td>Strain, strain background (mouse)</td><td>C57Bl/10 (WT)</td><td>JAX</td><td>Stock# 000665 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:MGI:5656893">MGI:5656893</ext-link></td><td colspan="2"/></tr><tr><td>Cell line (mouse)</td><td>C<sub>2</sub>C<sub>12</sub></td><td>ATCC</td><td>C3H <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:CVCL_UR38">CVCL_UR38</ext-link></td><td colspan="2"/></tr><tr><td>Cell line (human)</td><td>Male myoblast (WT)</td><td>Telethon Biobank</td><td>N/A</td><td colspan="2"/></tr><tr><td>Antibody</td><td>Anti-CD31-PE (cell line monoclonal)</td><td>MiltenyBiotec</td><td>Cat# 130111540 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2657296">AB_2657296</ext-link></td><td colspan="2">(1:25)</td></tr><tr><td>Antibody</td><td>Anti-CD45-PE (cell line monoclonal)</td><td>MiltenyBiotec</td><td>Cat# 130110797 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2658218">AB_2658218</ext-link></td><td colspan="2">(1:25)</td></tr><tr><td>Antibody</td><td>Anti-Ter119-PE <break/>(cell line monoclonal)</td><td>MiltenyBiotec</td><td>Cat# 130112909 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2654115">AB_2654115</ext-link></td><td colspan="2">(1:25)</td></tr><tr><td>Antibody</td><td>Anti-Sca1-FITC (cell line monoclonal)</td><td>MiltenyBiotec</td><td>Cat# 130116490 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2751322">AB_2751322</ext-link></td><td colspan="2">(1:50)</td></tr><tr><td>Antibody</td><td>Anti-α7Integrin-APCVio770 (cell line monoclonal)</td><td>MiltenyBiotec</td><td>Cat# 130095212 <break/>Custom</td><td colspan="2">(1:20)</td></tr><tr><td>Antibody</td><td>Anti-G9a (rabbit monoclonal)</td><td>Abcam</td><td>Cat# ab185050 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2792982">AB_2792982</ext-link></td><td colspan="2">(CLIP, RIP: 10 ug; <break/>ChIP: 5 ug; <break/>WB: 1:1000; <break/>IF: 1:100)</td></tr><tr><td>Antibody</td><td>Anti-EZH2 (mouse monoclonal)</td><td>Cell Signaling</td><td>Cat# 3147 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10694383">AB_10694383</ext-link></td><td colspan="2">(RIP: 5 ug; <break/>WB: 1:1000)</td></tr><tr><td>Antibody</td><td>Anti-GAPDH (rabbit polyclonal)</td><td>Sigma–Aldrich</td><td>Cat# G9545 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_796208">AB_796208</ext-link></td><td colspan="2">(1:10000)</td></tr><tr><td>Antibody</td><td>Anti-MyHC (mouse monoclonal)</td><td>DSHB</td><td>Cat# Mf20-s <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2147781">AB_2147781</ext-link></td><td colspan="2">(1:20)</td></tr><tr><td>Antibody</td><td>Anti-CyclinD3 (rabbit polyclonal)</td><td>Santa Cruz Biotechnology</td><td>Cat# sc-182 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2259653">AB_2259653</ext-link></td><td colspan="2">(1:200)</td></tr><tr><td>Antibody</td><td>Anti-Wnt7b (rabbit polyclonal)</td><td>Abcam</td><td>Cat#ab94915 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10675749">AB_10675749</ext-link></td><td colspan="2">(1:200)</td></tr><tr><td>Antibody</td><td>Anti-H<sub>3</sub>K<sub>9</sub>me<sub>2</sub>(mouse monoclonal)</td><td>Abcam</td><td>Cat# ab1220 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_449854">AB_449854</ext-link></td><td colspan="2">(ChIP: 5 ug)</td></tr><tr><td>Antibody</td><td>Anti-Pax7 (mouse monoclonal)</td><td>DSHB</td><td>Cat# Pax7-s <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2299243">AB_2299243</ext-link></td><td colspan="2">(1:10)</td></tr><tr><td>Antibody</td><td>IgG Anti-Rabbit</td><td>Invitrogen</td><td>Cat# 14-4616-82 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2865072">AB_2865072</ext-link></td><td colspan="2">(CLIP, RIP:10 ug; <break/>ChIP: 5 ug)</td></tr><tr><td>Antibody</td><td>Donkey anti-rabbit IgG Alexa Fluor Plus 647</td><td>Invitrogen</td><td>Cat# A32795 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2762835">AB_2762835</ext-link></td><td colspan="2">(1:300)</td></tr><tr><td>Antibody</td><td>Anti-Ki67 (rabbit polyclonal)</td><td>Abcam</td><td>Cat# ab15580 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_443209">AB_443209</ext-link></td><td colspan="2">(1:100)</td></tr><tr><td>Sequence-based reagent</td><td>siRNA: nontargeting control</td><td>Sigma–Aldrich</td><td>Cat# SIC007</td><td colspan="2"/></tr><tr><td>Sequence-based reagent</td><td>LNA Gapmer: nontargeting control</td><td>Qiagen</td><td>Cat# 300610</td><td colspan="2"/></tr><tr><td>Sequence-based reagent</td><td>Mir-Let7-b</td><td>Qiagen</td><td>Cat# MS00003122</td><td colspan="2"/></tr><tr><td>Sequence-based reagent</td><td>Mir-Let7-c</td><td>Qiagen</td><td>Cat# 18300</td><td colspan="2"/></tr><tr><td>Sequence-based reagent</td><td>siG9a</td><td>Sigma–Aldrich</td><td>SASI_Mm01_00136174 <break/>SASI_Mm_00136174_AS <break/>SASI_Mm01_00136175 <break/>SASI_Mm01_00136175_AS</td><td colspan="2"/></tr><tr><td>Sequence-based reagent</td><td>siWnt7b</td><td>Sigma–Aldrich</td><td>SASI_MM02_00316332 <break/>SASI_MM02_00316332_AS <break/>SASI_MM01_00033690 <break/>SASI_MM01_00033690_AS</td><td colspan="2"/></tr><tr><td>Sequence-based reagent</td><td>HS-DLC1 mRNA probe set</td><td>Advanced Cell Diagnostics, Inc</td><td>Ref. 716041</td><td colspan="2"/></tr><tr><td>Sequence-based reagent</td><td>Wnt7b BAC probe</td><td>Invitrogen clones</td><td>RP23-272K17</td><td colspan="2"/></tr><tr><td>Sequence-based reagent</td><td>NCTC BAC probe</td><td>Invitrogen clones</td><td>RP23-352B6</td><td colspan="2"/></tr><tr><td>Sequence-based reagent</td><td>Mm-Lnc-Rewind probe set</td><td>Advanced Cell Diagnostics, Inc</td><td>Ref. 722581</td><td colspan="2"/></tr><tr><td>Chemical compound, drug</td><td>TriReagent</td><td>Sigma</td><td>Cat#T9424</td><td colspan="2"/></tr><tr><td>Chemical compound, drug</td><td>DAPI</td><td>Sigma</td><td>Cat# 28718-90-3</td><td colspan="2">(1:10000)</td></tr><tr><td>Chemical compound, drug</td><td>DSG (di-succinimidyl glutarate)</td><td>Santa Cruz Biotechnology</td><td>CAS 79642-50-5</td><td colspan="2"/></tr><tr><td>Commercial assay or kit</td><td>SYBR Green Master mix</td><td>ThermoFisher Scientific</td><td>Cat# A25742</td><td colspan="2"/></tr><tr><td>Commercial assay or kit</td><td>Paris Kit</td><td>Thermo fisher scientific</td><td>Cat# AM1921</td><td colspan="2"/></tr><tr><td>Commercial assay or kit</td><td>Direct-Zol RNA MiniPrep Kit</td><td>Zymo Research</td><td>Cat# R2050</td><td colspan="2"/></tr><tr><td>Commercial assay or kit</td><td>MAGnify ChIP</td><td>ThermoFisher Scientific</td><td>Cat# 492024</td><td colspan="2"/></tr><tr><td>Commercial assay or kit</td><td>MyTaq DNA polymerase</td><td>Bioline</td><td>Cat# bio-21105</td><td colspan="2"/></tr><tr><td>Commercial assay or kit</td><td>SuperScript RT Vilo Master Mix</td><td>ThermoFisher Scientific</td><td>Cat# 11754050</td><td colspan="2"/></tr><tr><td>Commercial assay or kit</td><td>BaseScope Reagent Kit v2-RED</td><td>Advanced Cell Diagnostics, Inc</td><td>Ref. 323900</td><td colspan="2"/></tr><tr><td>Commercial assay or kit</td><td>MiScript II RT kit</td><td>Qiagen</td><td>Cat# 218160</td><td colspan="2"/></tr><tr><td>Commercial assay or kit</td><td>Lipofectamine 2000</td><td>Invitrogen</td><td>Cat# 11668019</td><td colspan="2"/></tr><tr><td>Commercial assay or kit</td><td>Click-iT EdU Alexa Flour 594 HCS Assay</td><td>Invitrogen</td><td>Cat# C10354</td><td colspan="2"/></tr><tr><td>Commercial assay or kit</td><td>Pierce ChIP-grade Protein A/G Magnetic Beads</td><td>ThermoFisher scientific</td><td>Cat# 26162</td><td colspan="2"/></tr><tr><td>Peptide, recombinant protein</td><td>Dispase II</td><td>Roche</td><td>4942078001</td><td colspan="2"/></tr><tr><td>Peptide, recombinant protein</td><td>Proteinase K</td><td>Roche</td><td>EO0491</td><td colspan="2"/></tr><tr><td>Peptide, recombinant protein</td><td>Collagenase A</td><td>Roche</td><td>10103578001</td><td colspan="2"/></tr><tr><td>Peptide, recombinant protein</td><td>DNase I</td><td>Roche</td><td>10104159001</td><td colspan="2"/></tr><tr><td>Peptide, recombinant protein</td><td>DNase I</td><td>ThermoFisher scientific</td><td>#EN0521</td><td colspan="2"/></tr><tr><td>Peptide, recombinant protein</td><td>Collagenase I</td><td>Sigma</td><td>C0130</td><td colspan="2"/></tr><tr><td>Software, algorithm</td><td>FACSDiva</td><td>BD Biosciences</td><td>Version 6.1.3.</td><td colspan="2"/></tr><tr><td>Software, algorithm</td><td>FlowJo</td><td>Tree Star</td><td>Version 9.3.2 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_008520">SCR_008520</ext-link></td><td colspan="2"/></tr><tr><td>Software, <break/>algorithm</td><td>Fiji image processing package</td><td>Open-source software (OSS) projects</td><td><ext-link ext-link-type="uri" xlink:href="https://imagej.net/Fiji">https://imagej.net/Fiji</ext-link> <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_002285">SCR_002285</ext-link></td><td colspan="2"/></tr><tr><td>Software, algorithm</td><td>MetaMorph</td><td>Molecular Devices</td><td><ext-link ext-link-type="uri" xlink:href="https://www.moleculardevices.com/">https://www.moleculardevices.com/</ext-link> <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_002368">SCR_002368</ext-link></td><td colspan="2"/></tr><tr><td>Software, algorithm</td><td>FV10-ASW Viewer software</td><td>Olympus</td><td><ext-link ext-link-type="uri" xlink:href="https://www.olympus-lifescience.com/">https://www.olympus-lifescience.com/</ext-link> <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_014215">SCR_014215</ext-link></td><td colspan="2"/></tr><tr><td>Software, algorithm</td><td>ZEN 3.0 Blue edition</td><td>ZEISS</td><td/><td colspan="2"/></tr></tbody></table></table-wrap><sec id="s4-1"><title>Cell preparation and FACS sorting</title><p>Cell isolation and labelling were essentially performed as described in <xref ref-type="bibr" rid="bib38">Mozzetta, 2016</xref>. Isolation of cells from 2 months old C57/Bl10 (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:MGI:5656893">MGI:5656893</ext-link>) WT mice was performed as follows: briefly, whole lower hindlimb muscles were carefully isolated, minced, and digested in phosphate-buffered saline (PBS) (Sigma) supplemented with 2.4 U/ml Dispase II (Roche), 100 μg/ml Collagenase A (Roche), 50 mM CaCl<sub>2</sub>, 1 M MgCl<sub>2</sub>, 10 mg/ml DNase I (Roche) for 1 hr at 37°C under agitation. Muscle slurries were passed 10 times through a 20G syringe (BD Bioscience). Cell suspension was obtained after three successive cycles of straining and washing in Washing Buffer consisting of HBSS containing 0.2% bovine serum albumin (BSA) (Sigma–Aldrich), 1% penicillin-streptomycin. Cells were incubated with primary antibodies CD31-PE (MiltenyBiotec, 130111540; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2657296">AB_2657296</ext-link>), CD45-PE (MiltenyBiotec, 139110797; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2658218">AB_2658218</ext-link>), Ter119-PE (MiltenyBiotec, 130112909; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2654115">AB_2654115</ext-link>) 1:25; Sca1-FITC (MiltenyBiotec, 130116490; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2751322">AB_2751322</ext-link>) 1:50; α7Integrin-APCVio770 (MiltenyBiotec, 130095212; Custom) 1:20 for 45 min on ice diluted in HBSS containing 0.2% BSA, 1% penicillin-streptomycin, and 1% DNAse I. The suspension was finally washed and resuspended in PBS containing 2% fetal bovine serum (FBS) and 0.5 μM ethylenediaminetetraacetic acid (EDTA). Cells were sorted using a FACSAriaIII (Becton Dickinson, BD Biosciences) equipped with 488 nm, 561 nm, and 633 nm laser and FACSDiva software (BD Biosciences, version 6.1.3). Data were analyzed using a FlowJo software (Tree Star, version 9.3.2). Briefly, cells were first gated based on morphology using forward versus side scatter area parameter (FSC-A versus SSC-A) strategy followed by doublets exclusion with morphology parameter area versus width (A versus W). Muscle satellite cells (MuSCs) were isolated as Ter119<sub>neg</sub>/CD45<sub>neg</sub>/CD31<sub>neg</sub>/a7-integrin<sub>pos</sub>/Sca1<sub>neg</sub> cells. To reduce stress, cells were isolated in gentle conditions using a ceramic nozzle of size 100 μm, a low sheath pressure of 19.84 pound-force per square inch (psi) that maintain the sample pressure at 18.96 psi and a maximum acquisition rate of 3000 events/s. Cells were collected in five polypropylene tubes. Following isolation, an aliquot of the sorted cells was evaluated for purity at the same instrument resulting in an enrichment &gt;98–99% (see <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C</xref>, right panel).</p></sec><sec id="s4-2"><title>Cell culture conditions and transfection</title><p>Freshly sorted cells were plated on ECM Gel (Sigma)-coated dishes in Cyto-grow (Resnova) complete medium as a growth medium (GM) and cultured at 37°C and 5% CO<sub>2</sub>. After 5 days in GM, MuSC-derived myoblasts were exposed, generally for 2 days, to differentiation medium consisting of Dulbecco’s modified Eagle’s medium (DMEM) with 5% horse serum (HS). Cells were counted on DAPI-stained images using the Fiji (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_002285">SCR_002285</ext-link>) tool ‘Multi point’. Downregulation of RNA expression was performed at ∼50% confluence by transfection in Lipofectamine 2000 (Invitrogen) according to manufacturer’s instructions, with 75 nM of LNA GapmeRs (Euroclone) for the downregulation of Lnc-Rewind and with siRNA (Sigma) for <italic>G9a</italic> and <italic>Wnt7b</italic>, according to manufacturer’s instructions. Negative Control A (Euroclone) (GAP-SCR) and Mission siRNA Universal Negative Control (Sigma) (si-SCR) were used as controls. See <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref> and Key resources table for details. MuSC-derived myoblasts were subjected to two consecutive (overnight) rounds of transfection in GM and harvested 24 hr after second transfection.</p><p>GapmeRs were designed against Lnc-Rewind sequence using the Exiqon web tool (<ext-link ext-link-type="uri" xlink:href="http://www.exiqon.com/ls/Pages">http://www.exiqon.com/ls/Pages</ext-link>). Negative Control A (Euroclone) was used as negative (Scramble) control. Sequences are reported in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref> and Key resources table.</p><p>For EdU (Invitrogen) detection cells were incubated for 6 hr and stained using Click-iT EdU Alexa Flour 594 HCS Assay (Invitrogen) according to the manufacturer’s instructions.</p></sec><sec id="s4-3"><title>Single myofibre isolation and immunofluorescence</title><p>Single myofibres were isolated from Extensor digitorum longus (EDL) muscles of C57/Bl10 mice and digested in 2 mg/ml collagenase I (Sigma) for 1 hr at 37°C, gently shacked every 10 min. Single fibres were obtained gently triturating the digested EDL muscles using a glass pipette in DMEM supplemented with 10% HS. The myofibres were manually collected under a dissecting microscope and cultured in DMEM + Pyr with 20% FBS, 2.5 ng/ml FGF (Gibco), and 1% chick embryo extract (CEE) (Life Science Production). RNAi experiments were performed 4 hr after plating with one round of transfection, as described above. The fibres were incubated for 24 hr with EdU (Invitrogen) and were analyzed 96 hr after plating.</p><p>For EdU detection cells were stained using Click-iT EdU Alexa Flour 594 HCS Assay (Invitrogen) according to the manufacturer’s instructions.</p><p>For the immunofluorescence, the single myofibres were fixed with 4% paraformaldehyde in PBS for 20 min at room temperature (RT), permeabilized with 0.5% Triton X-100 in PBS, and blocked with 10% FBS in PBS for 1 hr at RT. Primary antibodies (Pax7 (DSHB, Pax7-s; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2299243">AB_2299243</ext-link>) 1:10 and Ki67 (Abcam, ab15580; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_443209">AB_443209</ext-link>) 1:100) were diluted in 10% FBS–PBS and incubated overnight at 4°C. After incubation for 1 hr with the appropriate secondary antibodies (Alexa Fluor 488 or 594, Thermo Fisher), nuclei were counterstained with DAPI (Sigma), and fibres were mounted on cover-glasses. Images were taken with Axio Observer microscope (ZEISS) and processed with ZEN 3.0 (Blue edition) software.</p></sec><sec id="s4-4"><title>RNA/DNA-FISH</title><p>Lnc-Rewind in situ hybridization analyses were performed as previously described (<xref ref-type="bibr" rid="bib49">Rossi et al., 2019</xref>). Briefly, proliferating MuSC-derived myoblasts and C<sub>2</sub>C<sub>12</sub> cells were cultured on pre-coated glass coverslips and then fixed in 4% paraformaldehyde/PBS (Electron Microscopy Sciences, Hatfield, PA). RNA hybridization and signal development were carried out using Basescope assay (Advanced Cell Diagnostics, Bio-Techne) and BA-Mm-Lnc-Rewind probe-set (ref. 722581) designed to detect three junction regions of Lnc-Rewind (exon/intron1, intron1/exon2, exon/intron2). A probe specific for exon junction exon1/exon2 of human Dlc1 mRNA (BA-HS-DLC1, ref. 716041) was used as negative control. Confocal images were acquired at Olympus IX73 spinning disk confocal microscope equipped with a Confocal Imager (CREST X‐LIGHT) plus CoolSNAP Myo CCD camera (Photometrics) and at Olympus iX83 FluoView1200 laser scanning confocal microscope. Stacks of images were taken automatically with 0.2 or 0.3 microns between the Z-slices using a 60x NA1.35 oil objective and 405/473/559/635 nm or 405/470/555/640 nm lasers subset, respectively. Filter setting for DAPI, Alexa Fluor 488, Cy3, and Alexa Fluor 594 was used. The images were collected with MetaMorph or FV10-ASW confocal image acquisition software, and post-acquisition processing was performed by FIJI software to the entire image. 3D viewer plugin was used to perform 3D-rendering. DNA-FISH were sequentially carried out after RNA-FISH staining according to <xref ref-type="bibr" rid="bib51">Santini et al., 2021</xref>. In particular, <italic>Wnt7b</italic> and negative control (corresponding to the <italic>nctc</italic> locus, previously used in <xref ref-type="bibr" rid="bib7">Ballarino et al., 2018</xref> and <xref ref-type="bibr" rid="bib16">Desideri et al., 2020</xref>) genomic regions were visualized by nick-translated BAC clones (RP23-272K17 and RP23-352B6, respectively) labelled with Green 496 [5-fluorescein] dUTP (Enzo Life-Sciences). Percentage of colocalized signals in RNA/DNA-FISH experiments were measured as percentage ratio (%) of punctate Lnc-Rewind signals localized on the same focal plane of <italic>Wnt7b</italic> and negative control genomic regions, with respect to the total of Lnc-Rewind signals. In particular, we analysed a total of 135 nuclei for Lnc-Rewind<italic>/Wnt7b</italic> and 126 nuclei for Lnc-Rewind/negative control, from three independent biological replicates. G9a Immunofluorescence was performed sequentially to RNA-FISH staining by incubation in blocking solution (1% goat serum/1% BSA/PBS) for 30 min at RT. G9a primary antibody (Abcam, ab185050) was incubated in 1% donkey serum/PBS overnight at 4°C, while secondary antibody (donkey anti-rabbit Alexa Fluor Plus 647, Invitrogen A32795) were applied in the same incubation buffer for 45 min at RT.</p></sec><sec id="s4-5"><title>RNA analyses</title><p>Total RNA from myoblasts/myotubes and MuSC-derived myoblasts was extracted with TriReagent (Sigma) using the Direct-Zol RNA MiniPrep Kit (Zymo Research) according to protocol specification. 0.5–1.0 µg of RNA were treated with RNase-free DNase I enzyme (Thermo scientific). Nuclear/cytoplasmic fractionation was performed using the Paris kit (Ambion, AM1921) according to the protocol specifications. RNA was reverse transcribed using the SuperScript VILO Master Mix (Thermo Scientific). Real-time quantitative PCRs were performed by using SYBR Green Master mix (Applied Biosystems), according to the manufacturer’s instructions. Relative expression values were normalized to the housekeeping <italic>Gapdh</italic> transcript.</p></sec><sec id="s4-6"><title>Western blot</title><p>Total proteins were prepared by resuspending cells in RIPA buffer (50 mM Tris–HCl pH 7.4, 150 mM NaCl, 0.1% sodium dodecyl sulphate (SDS), 0.5% sodium deoxycholate, 1% NP-40, 1 mM EDTA, protease and phosphatase inhibitors [Roche]). Protein concentration was determined using a BCA assay (ThermoFisher Scientific). The cell lysate was denatured at 95°C for 5 min. The cell lysates were resolved on 4–15% TGX gradient gels (Bio-Rad Laboratories) and transferred to nitrocellulose membrane (Amersham). Membranes were blocked with 5% non-fat dried milk in TBS with 0.2% Tween for 1 hr at RT and then incubated with primary antibody overnight at 4°C. Primary antibodies used were against MF20 (MyHC) (DSHB, Mf20-s; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2147781">AB_2147781</ext-link>), G9a (Abcam, ab185050; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2792982">AB_2792982</ext-link>), Ezh2 (Cell Signaling, #3147; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10694383">AB_10694383</ext-link>), Wnt7b (Abcam, ab94915; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10675749">AB_10675749</ext-link>), Cyclin D3 (Santa Cruz biotechnology, sc-182; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2259653">AB_2259653</ext-link>), and GAPDH (Sigma, G9545; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_796208">AB_796208</ext-link>). After washing in TBS with 0.2% Tween, membranes were incubated in HRP-conjugated specific secondary antibody (goat anti-rabbit-anti-mouse [IgG-HRP Santa Cruz Biotechnologies]) for 1 hr at RT. After washing in TBS with 0.2% Tween, blots were developed with Western lightning enhanced chemiluminescence (ThermoFisher Scientific), the signal detection was performed with the use of ChemiDoc (Bio-Rad).</p></sec><sec id="s4-7"><title>RNA immunoprecipitation</title><p>C<sub>2</sub>C<sub>12</sub> cells were washed with PBS, centrifuged at 2000 rpm for 5 min and resuspended in Buffer A (20 mM Tris–HCl pH 8.0, 10 mM NaCl, 3 mM MgCl<sub>2</sub>, 0.1% NP40, 10% glycerol, 0.2 mM EDTA, 0.4 mM phenylmethylsulfonyl fluoride (PMSF), 1× Protease Inhibitor cocktail (PIC). After a 15 min incubation on ice, the cell suspension was centrifuged at 2000 rpm for 5 min at 4°C to pellet the nuclei. The supernatant was collected as cytoplasmic extract. The pellet was re-washed with Buffer A for three times. The pellet was resuspended in NT2/Wash buffer (50 mM Tris pH 7.4, 150 mM NaCl, 1 mM MgCl<sub>2</sub>, 0.5% NP40, 20 mM EDTA, 1× PIC, 1× phenylmethylsulfonyl fluoride (PMSF), 1 mM dithiothreitol [DTT]), break with 7 ml dounce (tight pestel/B pestel), and centrifuged at 14,000 rpm for 30 min at 4°C. Protein A/G Magnetic beads (Thermo Scientific) were incubate with IgG (Invitrogen, 14-4616-82; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2865072">AB_2865072</ext-link>), G9a (Abcam, ab185050; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2792982">AB_2792982</ext-link>), and Ezh2 (Cell Signaling, #3147; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10694383">AB_10694383</ext-link>) antibody on rotating wheel ON at 4°C, while the nuclear extract (NE) was precleared with the beads. Ten percent of the NE was collected for INP. The NE was divided in each sample with the coated beads (beads + Ab) and incubates on rotating wheel ON at 4°C. The beads were washed with NT2 buffer, and ¼ was collected for protein and ¾ for RNA analyses. RIP qRT-PCR results were represented as percentage of IP/input signal (% input).</p></sec><sec id="s4-8"><title>Crosslinking immunoprecipitation</title><p>CLIP experiments were performed on NE obtained with some modification of the Rinn et al.’s protocol (<xref ref-type="bibr" rid="bib46">Rinn et al., 2007</xref>). Briefly, C<sub>2</sub>C<sub>12</sub> cells were washed with PBS, crosslinked with UV rays and collected in Buffer A (20 mM Tris–HCl pH 8.0, 10 mM NaCl, 3 mM MgCl<sub>2</sub>, 0.1% NP40, 10% glycerol, 0.2 mM EDTA, 0.4 mM PMSF, 1× PIC). Cells were centrifuged at 500 x g for 10 min and the supernatant was collected as cytoplasmic extract. The nuclei pellet was re-washed with Buffer A for three times. After the last wash, the nuclei pellet was resuspended in NP40 lysis buffer (50 mM HEPES–KOH, 150 Mm KCl, 2 Mm EDTA, 1 Mm NaF, 0.5% NP40 pH 7.4, 0.5 Mm DTT, 100× PIC), break with 7 ml dounce (tight pestel/B pestel) and centrifuged at maximum speed for 20 min at 4°C. The supernatant was collected and quantified with Bradford assay. Ten percent of the NE was collected for INP. Protein A/G Magnetic beads (Thermo Scientific) were washed with PBS Tween 0.02% (1× PBS, 0.02% Tween-20) and incubated in PBS Tween 0.02% with IgG (Invitrogen, 14-4616-82; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2865072">AB_2865072</ext-link>) and G9a (Abcam, ab185050; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2792982">AB_2792982</ext-link>) antibody on rotating wheel 1 hr at RT. The NE was divided in each sample with the coated beads (beads + Ab) and incubated on rotating wheel ON at 4°C. The beads were washed three times with the NP40 High Salt Buffer 0.5. (25 mM HEPES–KOH pH7.5, 250 mM KCl, 0.025% NP40) and two times with polynucleotide kinase PNK Buffer (50 mM Tris–HCL, 50 Mm NaCl, 10 mM MgCl<sub>2</sub> pH 7.5) and resuspended in 100 μl of NP40 lysis buffer. Seventy-five microlitres were collected for RNA analysis: an equal volume of 2× Proteinase K Buffer (100 mM Tris–HCl, pH 7.5, 150 mM NaCl, 12.5 mM EDTA, 2% [wt/vol] SDS) was added, followed by the addition of Proteinase K (Roche) to a final concentration of 1.2 mg/ml and incubated for 30 min at 55°C. The RNA was recovered and analyzed through qRT-PCR. Twenty-five microlitres were heated at 95°C for 5 min, and the supernatant collected and resuspended in Protein elution buffer (4× Laemmli sample buffer [Bio-Rad]) with DTT 50 mM and analyzed by Western blot.</p></sec><sec id="s4-9"><title>RNA pulldown</title><p>RNA pulldown experiments were performed on NE obtained with some modification of the Rinn et al.’s protocol (<xref ref-type="bibr" rid="bib46">Rinn et al., 2007</xref>). C<sub>2</sub>C<sub>12</sub> cells were washed with PBS and harvested in Buffer A (20 mM Tris–HCl pH 8.0, 10 mM NaCl, 3 mM MgCl<sub>2</sub>, 0.1% NP40, 10% glycerol, 0.2 mM EDTA, 0.4 mM PMSF, 1× PIC). After a 15 min incubation on ice, they were centrifuged at 2000 rpm for 5 min at 4°C to pellet the nuclei. After three washes performed with Buffer A, the pellet was resuspended in NT2 buffer (50 mM Tris pH7.4, 150 mM NaCl, 1 mM MgCl<sub>2</sub>, 0.5% NP40, 20 mM EDTA, 1× PIC, 1× PMSF, 1 mM DTT), broken with 1 ml dounce (tight pestel/B pestel) and centrifuged at 14,000 rpm for 30 min at 4°C. The supernatant was quantified with Bradford assay. Streptavidin magnetic beads (Promega) were incubated with biotinylated primers against Lnc-Rewind and LacZ on a rotating wheel for 30 min at RT, while the NE was precleared with the beads with the same conditions. One percent of the NE was collected for INP. The NE was divided in each sample with the coated beads (beads + primers) and incubated on rotating wheel for 2 hr at RT. The beads were washed with NT2 buffer and 1/5 was collected for the RNA. The remaining 4/5 were eluted in elution buffer (2% SDS, 10% glycerol, 62.5 mM Tris–HCl pH 7.5, 0.5 M DTT, 1× PIC) and incubated 15 min at 70° before incubation of 5 min at 90° in order to collect proteins. Pulldown (PD) qRT-PCR results were represented as percentage of PD/input signal (% input).</p></sec><sec id="s4-10"><title>Chromatin immunoprecipitation</title><p>ChIP experiments on MuSC-derived myoblasts were performed on chromatin extracts according to the manufacturer's protocol (MAGnify ChIP; Life Technologies) by O.N. incubation with 3 μg of immobilized anti-H3K9me2 (Abcam ab1220; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_449854">AB_449854</ext-link>) or rabbit IgG (14-4616-82; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2865072">AB_2865072</ext-link>) antibodies. A standard curve was generated for each primer pair testing 5-point dilutions of input sample. Fold enrichment was quantified using qRT-PCR (SYBR Green; Qiagen) and calculated as a percentage of input chromatin (% Inp). Data from GAP-SCR vs GAP‐REW conditions represent the mean of six independent experiments ± SEM. For G9a ChIP experiments on proliferating C<sub>2</sub>C<sub>12</sub>, crosslinking was performed by adding DSG (di-succinimidyl glutarate; Santa Cruz) at a final concentration of 2 mM for 45 min at RT. Then, formaldehyde (Sigma) was added to culture medium to a final concentration of 1% for 10 min at RT and stopped by glycine to a final concentration of 0.125 M. Chromatin was extracted as described in <xref ref-type="bibr" rid="bib36">Mozzetta et al., 2014</xref> and immunoprecipitated with 5 μg of G9a (Abcam, ab185050; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2792982">AB_2792982</ext-link>) or rabbit IgG (14-4616-82; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2865072">AB_2865072</ext-link>) antibodies carried out overnight at 4°C. Sequences of the oligonucleotides used for ChIP analyses are reported in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>.</p></sec><sec id="s4-11"><title>3′-End mRNA sequencing and bioinformatic analyses</title><p>Total RNA was quantified using the Qubit 2.0 Fluorimetric Assay (ThermoFisher Scientific). Libraries were prepared from 100 ng of total RNA using the QuantSeq 3′ mRNA-Seq Library Prep Kit FWD for Illumina (Lexogen GmbH); the quality was assessed by using screen tape high-sensitivity DNA D1000 (Agilent Technologies). Sequencing was performed on a NextSeq 500 using a high-output single-end, 75 cycles, v2 Kit (Illumina Inc). Illumina novaSeq base call (BCL) files were converted in fastq file through bcl2fastq (version v2.20.0.422). Sequence reads were trimmed using trimgalore (v0.4.1) to remove adapter sequences and low-quality end bases (regions with average quality below Phred score 20). Alignment was performed with STAR 2.5.3a (<xref ref-type="bibr" rid="bib17">Dobin et al., 2013</xref>) on mm10 reference. The expression levels of genes were determined with htseq-count 0.9.1 (<xref ref-type="bibr" rid="bib3">Anders et al., 2015</xref>) by using mm10 Ensembl assembly (release 90). Genes having &lt;1 count per million in at least four samples and those with a percentage of multi-mapping reads &gt; 20% were filtered out. Paired t-test was performed to select differentially expressed genes in GAP-REW vs GAP-SCR conditions, setting 0.05 as p-value threshold. Gene Ontology term enrichment analyses were performed using GORILLA (<xref ref-type="bibr" rid="bib18">Eden et al., 2009</xref>) by providing the list of genes expressed in at least one of the two conditions as background.</p><p>RNA-Seq reads from WT myoblasts cultured in GM (<xref ref-type="bibr" rid="bib31">Legnini et al., 2017</xref>) were downloaded from GEO (GSE70389), preprocessed using Trimmomatic 0.32 software (<xref ref-type="bibr" rid="bib9">Bolger et al., 2014</xref>), and aligned to human GRCh38 assembly using STAR 2.5.3a. The normalized read coverage tracks (.tdf files) were created and loaded on IGV genome browser (<xref ref-type="bibr" rid="bib48">Robinson et al., 2011</xref>).</p></sec><sec id="s4-12"><title>Statistical analyses</title><p>The statistical analyses were performed using Microsoft Excel (v16). The use of an unpaired or paired two-tailed Student’s t-test is specified in each figure legend. For the data that did not show a normal distribution, the Spearman’s rank correlation test was used. When more than two conditions were compared, one-way Anova with Tukey’s multiple comparison test was applied using Prism (v9). Statistical significance was set at p&lt;0.05.</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>The authors acknowledge Marcella Marchioni for technical help. The authors wish to dedicate this manuscript to all researchers, volunteers, and people in healthcare organizations operating around the world to fight coronavirus disease 2019 (COVID-19) infections.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Supervision, Validation, Investigation, Visualization, Methodology, Writing - review and editing, Performed the cellular and molecular experiments in C2C12 cells, RNA-seq analysis, TSS usage analysis, Gene Ontologies studies, H3K9me2 ChIP experiments and the statistical analyses</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Data curation, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing - review and editing, performed and analyzed the cellular and molecular experiments carried out on MuSCs and myofibres, RIP, CLIP and G9a ChIP experiments on C2C12, Giulia Buonaiuto, Formal analysis, Validation, Visualization, contributed to the molecular experiments performed in C2C12 and MuSCs cells and H3K9me2 ChIP experiments, performed RNA pull-down</p></fn><fn fn-type="con" id="con3"><p>Formal analysis, Validation, Visualization, contributed to the molecular analyses performed in C2C12 and MuSCs cells</p></fn><fn fn-type="con" id="con4"><p>Methodology, performed RNA-FISH, RNA/DNA-FISH and RNA/DNA/IF experiments</p></fn><fn fn-type="con" id="con5"><p>Methodology, contributed to the cellular experiments on MuSCs and myofibres</p></fn><fn fn-type="con" id="con6"><p>Methodology, perfomed FACS isolation of MuSCs</p></fn><fn fn-type="con" id="con7"><p>Software, performed the bioinformatic analysis of the human myoblast RNA-seq</p></fn><fn fn-type="con" id="con8"><p>Conceptualization, Resources, Data curation, Supervision, Funding acquisition, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con9"><p>Conceptualization, Resources, Data curation, Supervision, Funding acquisition, Writing - original draft, Writing - review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other" id="fn1"><p>Animal experimentation: For the experiments described in this study, C57/BL10 wild-type mice were used and differences that were observed in both male and female mice were included in experiments. Animals were treated in respect to housing, nutrition and care according to the guidelines of Good laboratory Practice (GLP). All experimental protocols (Protocol N° 7FF2C.4 -Authorization N° 746/2016-PR) were approved and conformed to the regulatory standards. All animals were kept in a temperature of 22°C ± 3°C with a humidity between 50% and 60%, in animal cages with at least five animals.</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>List and sequences of the oligonucleotides, LNA gapmers, and siRNAs used.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-54782-supp1-v2.xlsx"/></supplementary-material><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-54782-transrepform-v2.docx"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>Sequencing data have been deposited in GEO under accession code GSE141396. All data generated or analysed during this study are included in the manuscript and supporting files.</p><p>The following dataset was generated:</p><p><element-citation id="dataset4" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Cipriano</surname><given-names>A</given-names></name><name><surname>Macino</surname><given-names>M</given-names></name><name><surname>Buonaiuto</surname><given-names>G</given-names></name><name><surname>Santini</surname><given-names>T</given-names></name><name><surname>Biferali</surname><given-names>B</given-names></name><name><surname>Colantoni</surname><given-names>A</given-names></name><name><surname>Peruzzi</surname><given-names>G</given-names></name><name><surname>Mozzetta</surname><given-names>C</given-names></name><name><surname>Ballarino</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2021">2021</year><data-title>3' mRNA-seq analysis from murine satellite cells upon lnc-Rewind knockdown</data-title><source>NCBI Gene Expression Omnibus</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE141396">GSE141396</pub-id></element-citation></p><p>The following previously published datasets were used:</p><p><element-citation id="dataset1" publication-type="data" specific-use="references"><person-group person-group-type="author"><name><surname>Ballarino</surname><given-names>M</given-names></name><name><surname>Cazzella</surname><given-names>V</given-names></name><name><surname>D'Andrea</surname><given-names>D</given-names></name><name><surname>Grassi</surname><given-names>L</given-names></name><name><surname>Bisceglie</surname><given-names>L</given-names></name><name><surname>Cipriano</surname><given-names>A</given-names></name><name><surname>Santini</surname><given-names>T</given-names></name><name><surname>Pinnarò</surname><given-names>C</given-names></name><name><surname>Morlando</surname><given-names>M</given-names></name><name><surname>Tramontano</surname><given-names>A</given-names></name><name><surname>Bozzoni</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2014">2014</year><data-title>Discovery of Novel LncRNA species differentially expressed during murine muscle differentiation</data-title><source>European Nucleotide Archive (ENA) accession number</source><pub-id assigning-authority="EBI" pub-id-type="accession" xlink:href="https://www.ebi.ac.uk/ena/browser/view/PRJEB6112">PRJEB6112</pub-id></element-citation></p><p><element-citation id="dataset2" publication-type="data" specific-use="references"><person-group person-group-type="author"><name><surname>Legnini</surname><given-names>I</given-names></name><name><surname>Briganti</surname><given-names>F</given-names></name><name><surname>Sthandier</surname><given-names>O</given-names></name><name><surname>Bozzoni</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2016">2016</year><data-title>Gene expression profiling of human and murine in vitro muscle differentiation</data-title><source>NCBI Gene Expression Omnibus</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE70389">GSE70389</pub-id></element-citation></p><p><element-citation id="dataset3" publication-type="data" specific-use="references"><person-group person-group-type="author"><name><surname>Arner</surname><given-names>E</given-names></name><name><surname>Daub</surname><given-names>CO</given-names></name><name><surname>Vitting-Seerup</surname><given-names>K</given-names></name><name><surname>Andersson</surname><given-names>R</given-names></name><name><surname>Lilje</surname><given-names>B</given-names></name><name><surname>Drablos</surname><given-names>F</given-names></name><name><surname>Lennartsson</surname><given-names>A</given-names></name><name><surname>Rönnerblad</surname><given-names>M</given-names></name><name><surname>Hrydziuszko</surname><given-names>O</given-names></name><name><surname>Vitezic</surname><given-names>M</given-names></name><name><surname>Freeman</surname><given-names>CT</given-names></name><name><surname>Alhendi</surname><given-names>A</given-names></name><name><surname>Arner</surname><given-names>P</given-names></name><name><surname>Axton</surname><given-names>R</given-names></name><name><surname>Baillie</surname><given-names>JK</given-names></name><name><surname>Beckhouse</surname><given-names>A</given-names></name><name><surname>Bodega</surname><given-names>B</given-names></name><name><surname>Briggs</surname><given-names>J</given-names></name><name><surname>Brombacher</surname><given-names>F</given-names></name><name><surname>Davis</surname><given-names>M</given-names></name><name><surname>Detmar</surname><given-names>M</given-names></name><name><surname>Ehrlund</surname><given-names>A</given-names></name><name><surname>Endoh</surname><given-names>M</given-names></name><name><surname>Eslami</surname><given-names>A</given-names></name><name><surname>Fagiolini</surname><given-names>M</given-names></name><name><surname>Fairbairn</surname><given-names>L</given-names></name><name><surname>Faulkner</surname><given-names>GJ</given-names></name><name><surname>Ferrai</surname><given-names>C</given-names></name><name><surname>Fisher</surname><given-names>ME</given-names></name><name><surname>Forrester</surname><given-names>L</given-names></name><name><surname>Goldowitz</surname><given-names>D</given-names></name><name><surname>Guler</surname><given-names>R</given-names></name><name><surname>Ha</surname><given-names>T</given-names></name><name><surname>Hara</surname><given-names>M</given-names></name><name><surname>Herlyn</surname><given-names>M</given-names></name><name><surname>Ikawa</surname><given-names>T</given-names></name><name><surname>Kai</surname><given-names>C</given-names></name><name><surname>Kawamoto</surname><given-names>H</given-names></name><name><surname>Khachigian</surname><given-names>L</given-names></name><name><surname>Klinken</surname><given-names>PS</given-names></name><name><surname>Kojima</surname><given-names>S</given-names></name><name><surname>Koseki</surname><given-names>H</given-names></name><name><surname>Klein</surname><given-names>S</given-names></name><name><surname>Mejhert</surname><given-names>N</given-names></name><name><surname>Miyaguchi</surname><given-names>K</given-names></name><name><surname>Mizuno</surname><given-names>Y</given-names></name><name><surname>Morimoto</surname><given-names>M</given-names></name><name><surname>Morris</surname><given-names>KJ</given-names></name><name><surname>Mummery</surname><given-names>C</given-names></name><name><surname>Nakachi</surname><given-names>Y</given-names></name><name><surname>Ogishima</surname><given-names>S</given-names></name><name><surname>Okada-Hatakeyama</surname><given-names>M</given-names></name><name><surname>Okazaki</surname><given-names>Y</given-names></name><name><surname>Orlando</surname><given-names>V</given-names></name><name><surname>Ovchinnikov</surname><given-names>D</given-names></name><name><surname>Passier</surname><given-names>R</given-names></name><name><surname>Patrikakis</surname><given-names>M</given-names></name><name><surname>Pombo</surname><given-names>A</given-names></name><name><surname>Qin</surname><given-names>X-Y</given-names></name><name><surname>Roy</surname><given-names>S</given-names></name><name><surname>Sato</surname><given-names>H</given-names></name><name><surname>Savvi</surname><given-names>S</given-names></name><name><surname>Saxena</surname><given-names>A</given-names></name><name><surname>Schwegmann</surname><given-names>A</given-names></name><name><surname>Sugiyama</surname><given-names>D</given-names></name><name><surname>Swoboda</surname><given-names>R</given-names></name><name><surname>Tanaka</surname><given-names>H</given-names></name><name><surname>Tomoiu</surname><given-names>A</given-names></name><name><surname>Winteringham</surname><given-names>LN</given-names></name><name><surname>Wolvetang</surname><given-names>E</given-names></name><name><surname>Yanagi-Mizuochi</surname><given-names>C</given-names></name><name><surname>Yoneda</surname><given-names>M</given-names></name><name><surname>Zabierowski</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>P</given-names></name><name><surname>Abugessaisa</surname><given-names>I</given-names></name><name><surname>Bertin</surname><given-names>N</given-names></name><name><surname>Diehl</surname><given-names>AD</given-names></name><name><surname>Fukuda</surname><given-names>S</given-names></name><name><surname>Furuno</surname><given-names>M</given-names></name><name><surname>Harshbarger</surname><given-names>J</given-names></name><name><surname>Hasegawa</surname><given-names>A</given-names></name><name><surname>Hori</surname><given-names>F</given-names></name><name><surname>Ishikawa-Kato</surname><given-names>S</given-names></name><name><surname>Ishizu</surname><given-names>Y</given-names></name><name><surname>Itoh</surname><given-names>M</given-names></name><name><surname>Kawashima</surname><given-names>T</given-names></name><name><surname>Kojima</surname><given-names>M</given-names></name><name><surname>Kondo</surname><given-names>N</given-names></name><name><surname>Lizio</surname><given-names>M</given-names></name><name><surname>Meehan</surname><given-names>TF</given-names></name><name><surname>Mungall</surname><given-names>CJ</given-names></name><name><surname>Murata</surname><given-names>M</given-names></name><name><surname>Nishiyori-Sueki</surname><given-names>H</given-names></name><name><surname>Sahin</surname><given-names>S</given-names></name><name><surname>Sato-Nagao</surname><given-names>S</given-names></name><name><surname>Severin</surname><given-names>J</given-names></name><name><surname>Kawai</surname><given-names>J</given-names></name><name><surname>Kasukawa</surname><given-names>T</given-names></name><name><surname>Lassmann</surname><given-names>T</given-names></name><name><surname>Suzuki</surname><given-names>H</given-names></name><name><surname>Kawaji</surname><given-names>H</given-names></name><name><surname>Summers</surname><given-names>KM</given-names></name><name><surname>Wells</surname><given-names>C</given-names></name><collab>FANTOM Consortium</collab><name><surname>Hume</surname><given-names>DA</given-names></name><name><surname>Forrest</surname><given-names>ARR</given-names></name><name><surname>Sandelin</surname><given-names>A</given-names></name><name><surname>Carninci</surname><given-names>P</given-names></name><name><surname>Hayashizaki</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2015">2015</year><data-title>Transcribed enhancers lead waves of coordinated transcription in transitioning mammalian cells</data-title><source>FANTOM5 Consortium</source><pub-id assigning-authority="other" pub-id-type="accession" xlink:href="https://fantom.gsc.riken.jp/5/data/">fantom</pub-id></element-citation></p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abugessaisa</surname> <given-names>I</given-names></name><name><surname>Noguchi</surname> <given-names>S</given-names></name><name><surname>Hasegawa</surname> <given-names>A</given-names></name><name><surname>Harshbarger</surname> <given-names>J</given-names></name><name><surname>Kondo</surname> <given-names>A</given-names></name><name><surname>Lizio</surname> <given-names>M</given-names></name><name><surname>Severin</surname> <given-names>J</given-names></name><name><surname>Carninci</surname> <given-names>P</given-names></name><name><surname>Kawaji</surname> <given-names>H</given-names></name><name><surname>Kasukawa</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>FANTOM5 CAGE profiles of human and mouse reprocessed for GRCh38 and GRCm38 genome assemblies</article-title><source>Scientific Data</source><volume>4</volume><elocation-id>170107</elocation-id><pub-id pub-id-type="doi">10.1038/sdata.2017.107</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agarwal</surname> <given-names>V</given-names></name><name><surname>Bell</surname> <given-names>GW</given-names></name><name><surname>Nam</surname> <given-names>J-W</given-names></name><name><surname>Bartel</surname> <given-names>DP</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Predicting effective microRNA target sites in mammalian mRNAs</article-title><source>eLife</source><volume>4</volume><elocation-id>e05005</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.05005</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anders</surname> <given-names>S</given-names></name><name><surname>Pyl</surname> <given-names>PT</given-names></name><name><surname>Huber</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>HTSeq--a Python framework to work with high-throughput sequencing data</article-title><source>Bioinformatics</source><volume>31</volume><fpage>166</fpage><lpage>169</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btu638</pub-id><pub-id pub-id-type="pmid">25260700</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Babicki</surname> <given-names>S</given-names></name><name><surname>Arndt</surname> <given-names>D</given-names></name><name><surname>Marcu</surname> <given-names>A</given-names></name><name><surname>Liang</surname> <given-names>Y</given-names></name><name><surname>Grant</surname> <given-names>JR</given-names></name><name><surname>Maciejewski</surname> <given-names>A</given-names></name><name><surname>Wishart</surname> <given-names>DS</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Heatmapper: web-enabled heat mapping for all</article-title><source>Nucleic Acids Research</source><volume>44</volume><fpage>W147</fpage><lpage>W153</lpage><pub-id pub-id-type="doi">10.1093/nar/gkw419</pub-id><pub-id pub-id-type="pmid">27190236</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ballarino</surname> <given-names>M</given-names></name><name><surname>Cazzella</surname> <given-names>V</given-names></name><name><surname>D'Andrea</surname> <given-names>D</given-names></name><name><surname>Grassi</surname> <given-names>L</given-names></name><name><surname>Bisceglie</surname> <given-names>L</given-names></name><name><surname>Cipriano</surname> <given-names>A</given-names></name><name><surname>Santini</surname> <given-names>T</given-names></name><name><surname>Pinnarò</surname> <given-names>C</given-names></name><name><surname>Morlando</surname> <given-names>M</given-names></name><name><surname>Tramontano</surname> <given-names>A</given-names></name><name><surname>Bozzoni</surname> <given-names>I</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Novel long noncoding RNAs (lncRNAs) in Myogenesis: a <italic>miR-31</italic> overlapping lncRNA transcript controls myoblast differentiation</article-title><source>Molecular and Cellular Biology</source><volume>35</volume><fpage>728</fpage><lpage>736</lpage><pub-id pub-id-type="doi">10.1128/MCB.01394-14</pub-id><pub-id pub-id-type="pmid">25512605</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ballarino</surname> <given-names>M</given-names></name><name><surname>Morlando</surname> <given-names>M</given-names></name><name><surname>Fatica</surname> <given-names>A</given-names></name><name><surname>Bozzoni</surname> <given-names>I</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Non-coding RNAs in muscle differentiation and musculoskeletal disease</article-title><source>Journal of Clinical Investigation</source><volume>126</volume><fpage>2021</fpage><lpage>2030</lpage><pub-id pub-id-type="doi">10.1172/JCI84419</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ballarino</surname> <given-names>M</given-names></name><name><surname>Cipriano</surname> <given-names>A</given-names></name><name><surname>Tita</surname> <given-names>R</given-names></name><name><surname>Santini</surname> <given-names>T</given-names></name><name><surname>Desideri</surname> <given-names>F</given-names></name><name><surname>Morlando</surname> <given-names>M</given-names></name><name><surname>Colantoni</surname> <given-names>A</given-names></name><name><surname>Carrieri</surname> <given-names>C</given-names></name><name><surname>Nicoletti</surname> <given-names>C</given-names></name><name><surname>Musarò</surname> <given-names>A</given-names></name><name><surname>Carroll</surname> <given-names>DO</given-names></name><name><surname>Bozzoni</surname> <given-names>I</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Deficiency in the nuclear long noncoding RNA <italic>charme</italic> causes myogenic defects and heart remodeling in mice</article-title><source>The EMBO Journal</source><volume>37</volume><elocation-id>e99697</elocation-id><pub-id pub-id-type="doi">10.15252/embj.201899697</pub-id><pub-id pub-id-type="pmid">30177572</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Batista</surname> <given-names>PJ</given-names></name><name><surname>Chang</surname> <given-names>HY</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Long noncoding RNAs: cellular address codes in development and disease</article-title><source>Cell</source><volume>152</volume><fpage>1298</fpage><lpage>1307</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2013.02.012</pub-id><pub-id pub-id-type="pmid">23498938</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bolger</surname> <given-names>AM</given-names></name><name><surname>Lohse</surname> <given-names>M</given-names></name><name><surname>Usadel</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Trimmomatic: a flexible trimmer for illumina sequence data</article-title><source>Bioinformatics</source><volume>30</volume><fpage>2114</fpage><lpage>2120</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btu170</pub-id><pub-id pub-id-type="pmid">24695404</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brack</surname> <given-names>AS</given-names></name><name><surname>Conboy</surname> <given-names>IM</given-names></name><name><surname>Conboy</surname> <given-names>MJ</given-names></name><name><surname>Shen</surname> <given-names>J</given-names></name><name><surname>Rando</surname> <given-names>TA</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>A temporal switch from notch to wnt signaling in muscle stem cells is necessary for normal adult myogenesis</article-title><source>Cell Stem Cell</source><volume>2</volume><fpage>50</fpage><lpage>59</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2007.10.006</pub-id><pub-id pub-id-type="pmid">18371421</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caretti</surname> <given-names>G</given-names></name><name><surname>Di Padova</surname> <given-names>M</given-names></name><name><surname>Micales</surname> <given-names>B</given-names></name><name><surname>Lyons</surname> <given-names>GE</given-names></name><name><surname>Sartorelli</surname> <given-names>V</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>The polycomb Ezh2 methyltransferase regulates muscle gene expression and skeletal muscle differentiation</article-title><source>Genes &amp; Development</source><volume>18</volume><fpage>2627</fpage><lpage>2638</lpage><pub-id pub-id-type="doi">10.1101/gad.1241904</pub-id><pub-id pub-id-type="pmid">15520282</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carlevaro</surname> <given-names>G</given-names></name><name><surname>Lantos</surname> <given-names>AB</given-names></name><name><surname>Cánepa</surname> <given-names>GE</given-names></name><name><surname>de Los Milagros Cámara</surname> <given-names>M</given-names></name><name><surname>Somoza</surname> <given-names>M</given-names></name><name><surname>Buscaglia</surname> <given-names>CA</given-names></name><name><surname>Campetella</surname> <given-names>O</given-names></name><name><surname>Mucci</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Metabolic labeling of surface Neo-sialylglyconjugates catalyzed by Trypanosoma cruzi trans-Sialidase</article-title><source>Methods in Molecular Biology</source><volume>1955</volume><fpage>135</fpage><lpage>146</lpage><pub-id pub-id-type="doi">10.1007/978-1-4939-9148-8_10</pub-id><pub-id pub-id-type="pmid">30868524</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carninci</surname> <given-names>P</given-names></name><name><surname>Kasukawa</surname> <given-names>T</given-names></name><name><surname>Katayama</surname> <given-names>S</given-names></name><name><surname>Gough</surname> <given-names>J</given-names></name><name><surname>Frith</surname> <given-names>MC</given-names></name><name><surname>Maeda</surname> <given-names>N</given-names></name><name><surname>Oyama</surname> <given-names>R</given-names></name><name><surname>Ravasi</surname> <given-names>T</given-names></name><name><surname>Lenhard</surname> <given-names>B</given-names></name><name><surname>Wells</surname> <given-names>C</given-names></name><name><surname>Kodzius</surname> <given-names>R</given-names></name><name><surname>Shimokawa</surname> <given-names>K</given-names></name><name><surname>Bajic</surname> <given-names>VB</given-names></name><name><surname>Brenner</surname> <given-names>SE</given-names></name><name><surname>Batalov</surname> <given-names>S</given-names></name><name><surname>Forrest</surname> <given-names>AR</given-names></name><name><surname>Zavolan</surname> <given-names>M</given-names></name><name><surname>Davis</surname> <given-names>MJ</given-names></name><name><surname>Wilming</surname> <given-names>LG</given-names></name><name><surname>Aidinis</surname> <given-names>V</given-names></name><name><surname>Allen</surname> <given-names>JE</given-names></name><name><surname>Ambesi-Impiombato</surname> <given-names>A</given-names></name><name><surname>Apweiler</surname> <given-names>R</given-names></name><name><surname>Aturaliya</surname> <given-names>RN</given-names></name><name><surname>Bailey</surname> <given-names>TL</given-names></name><name><surname>Bansal</surname> <given-names>M</given-names></name><name><surname>Baxter</surname> <given-names>L</given-names></name><name><surname>Beisel</surname> <given-names>KW</given-names></name><name><surname>Bersano</surname> <given-names>T</given-names></name><name><surname>Bono</surname> <given-names>H</given-names></name><name><surname>Chalk</surname> <given-names>AM</given-names></name><name><surname>Chiu</surname> <given-names>KP</given-names></name><name><surname>Choudhary</surname> <given-names>V</given-names></name><name><surname>Christoffels</surname> <given-names>A</given-names></name><name><surname>Clutterbuck</surname> <given-names>DR</given-names></name><name><surname>Crowe</surname> <given-names>ML</given-names></name><name><surname>Dalla</surname> <given-names>E</given-names></name><name><surname>Dalrymple</surname> <given-names>BP</given-names></name><name><surname>de Bono</surname> <given-names>B</given-names></name><name><surname>Della Gatta</surname> <given-names>G</given-names></name><name><surname>di Bernardo</surname> <given-names>D</given-names></name><name><surname>Down</surname> <given-names>T</given-names></name><name><surname>Engstrom</surname> <given-names>P</given-names></name><name><surname>Fagiolini</surname> <given-names>M</given-names></name><name><surname>Faulkner</surname> <given-names>G</given-names></name><name><surname>Fletcher</surname> <given-names>CF</given-names></name><name><surname>Fukushima</surname> <given-names>T</given-names></name><name><surname>Furuno</surname> <given-names>M</given-names></name><name><surname>Futaki</surname> <given-names>S</given-names></name><name><surname>Gariboldi</surname> <given-names>M</given-names></name><name><surname>Georgii-Hemming</surname> <given-names>P</given-names></name><name><surname>Gingeras</surname> <given-names>TR</given-names></name><name><surname>Gojobori</surname> <given-names>T</given-names></name><name><surname>Green</surname> <given-names>RE</given-names></name><name><surname>Gustincich</surname> <given-names>S</given-names></name><name><surname>Harbers</surname> <given-names>M</given-names></name><name><surname>Hayashi</surname> <given-names>Y</given-names></name><name><surname>Hensch</surname> <given-names>TK</given-names></name><name><surname>Hirokawa</surname> <given-names>N</given-names></name><name><surname>Hill</surname> <given-names>D</given-names></name><name><surname>Huminiecki</surname> <given-names>L</given-names></name><name><surname>Iacono</surname> <given-names>M</given-names></name><name><surname>Ikeo</surname> <given-names>K</given-names></name><name><surname>Iwama</surname> <given-names>A</given-names></name><name><surname>Ishikawa</surname> <given-names>T</given-names></name><name><surname>Jakt</surname> <given-names>M</given-names></name><name><surname>Kanapin</surname> <given-names>A</given-names></name><name><surname>Katoh</surname> <given-names>M</given-names></name><name><surname>Kawasawa</surname> <given-names>Y</given-names></name><name><surname>Kelso</surname> <given-names>J</given-names></name><name><surname>Kitamura</surname> <given-names>H</given-names></name><name><surname>Kitano</surname> <given-names>H</given-names></name><name><surname>Kollias</surname> <given-names>G</given-names></name><name><surname>Krishnan</surname> <given-names>SP</given-names></name><name><surname>Kruger</surname> <given-names>A</given-names></name><name><surname>Kummerfeld</surname> <given-names>SK</given-names></name><name><surname>Kurochkin</surname> <given-names>IV</given-names></name><name><surname>Lareau</surname> <given-names>LF</given-names></name><name><surname>Lazarevic</surname> <given-names>D</given-names></name><name><surname>Lipovich</surname> <given-names>L</given-names></name><name><surname>Liu</surname> <given-names>J</given-names></name><name><surname>Liuni</surname> <given-names>S</given-names></name><name><surname>McWilliam</surname> <given-names>S</given-names></name><name><surname>Madan Babu</surname> <given-names>M</given-names></name><name><surname>Madera</surname> <given-names>M</given-names></name><name><surname>Marchionni</surname> <given-names>L</given-names></name><name><surname>Matsuda</surname> <given-names>H</given-names></name><name><surname>Matsuzawa</surname> <given-names>S</given-names></name><name><surname>Miki</surname> <given-names>H</given-names></name><name><surname>Mignone</surname> <given-names>F</given-names></name><name><surname>Miyake</surname> <given-names>S</given-names></name><name><surname>Morris</surname> <given-names>K</given-names></name><name><surname>Mottagui-Tabar</surname> <given-names>S</given-names></name><name><surname>Mulder</surname> <given-names>N</given-names></name><name><surname>Nakano</surname> <given-names>N</given-names></name><name><surname>Nakauchi</surname> <given-names>H</given-names></name><name><surname>Ng</surname> <given-names>P</given-names></name><name><surname>Nilsson</surname> <given-names>R</given-names></name><name><surname>Nishiguchi</surname> <given-names>S</given-names></name><name><surname>Nishikawa</surname> <given-names>S</given-names></name><name><surname>Nori</surname> <given-names>F</given-names></name><name><surname>Ohara</surname> <given-names>O</given-names></name><name><surname>Okazaki</surname> <given-names>Y</given-names></name><name><surname>Orlando</surname> <given-names>V</given-names></name><name><surname>Pang</surname> <given-names>KC</given-names></name><name><surname>Pavan</surname> <given-names>WJ</given-names></name><name><surname>Pavesi</surname> <given-names>G</given-names></name><name><surname>Pesole</surname> <given-names>G</given-names></name><name><surname>Petrovsky</surname> <given-names>N</given-names></name><name><surname>Piazza</surname> <given-names>S</given-names></name><name><surname>Reed</surname> <given-names>J</given-names></name><name><surname>Reid</surname> <given-names>JF</given-names></name><name><surname>Ring</surname> <given-names>BZ</given-names></name><name><surname>Ringwald</surname> <given-names>M</given-names></name><name><surname>Rost</surname> <given-names>B</given-names></name><name><surname>Ruan</surname> <given-names>Y</given-names></name><name><surname>Salzberg</surname> <given-names>SL</given-names></name><name><surname>Sandelin</surname> <given-names>A</given-names></name><name><surname>Schneider</surname> <given-names>C</given-names></name><name><surname>Schönbach</surname> <given-names>C</given-names></name><name><surname>Sekiguchi</surname> <given-names>K</given-names></name><name><surname>Semple</surname> <given-names>CA</given-names></name><name><surname>Seno</surname> <given-names>S</given-names></name><name><surname>Sessa</surname> <given-names>L</given-names></name><name><surname>Sheng</surname> <given-names>Y</given-names></name><name><surname>Shibata</surname> <given-names>Y</given-names></name><name><surname>Shimada</surname> <given-names>H</given-names></name><name><surname>Shimada</surname> <given-names>K</given-names></name><name><surname>Silva</surname> <given-names>D</given-names></name><name><surname>Sinclair</surname> <given-names>B</given-names></name><name><surname>Sperling</surname> <given-names>S</given-names></name><name><surname>Stupka</surname> <given-names>E</given-names></name><name><surname>Sugiura</surname> <given-names>K</given-names></name><name><surname>Sultana</surname> <given-names>R</given-names></name><name><surname>Takenaka</surname> <given-names>Y</given-names></name><name><surname>Taki</surname> <given-names>K</given-names></name><name><surname>Tammoja</surname> <given-names>K</given-names></name><name><surname>Tan</surname> <given-names>SL</given-names></name><name><surname>Tang</surname> <given-names>S</given-names></name><name><surname>Taylor</surname> <given-names>MS</given-names></name><name><surname>Tegner</surname> <given-names>J</given-names></name><name><surname>Teichmann</surname> <given-names>SA</given-names></name><name><surname>Ueda</surname> <given-names>HR</given-names></name><name><surname>van Nimwegen</surname> <given-names>E</given-names></name><name><surname>Verardo</surname> <given-names>R</given-names></name><name><surname>Wei</surname> <given-names>CL</given-names></name><name><surname>Yagi</surname> <given-names>K</given-names></name><name><surname>Yamanishi</surname> <given-names>H</given-names></name><name><surname>Zabarovsky</surname> <given-names>E</given-names></name><name><surname>Zhu</surname> <given-names>S</given-names></name><name><surname>Zimmer</surname> <given-names>A</given-names></name><name><surname>Hide</surname> <given-names>W</given-names></name><name><surname>Bult</surname> <given-names>C</given-names></name><name><surname>Grimmond</surname> <given-names>SM</given-names></name><name><surname>Teasdale</surname> <given-names>RD</given-names></name><name><surname>Liu</surname> <given-names>ET</given-names></name><name><surname>Brusic</surname> <given-names>V</given-names></name><name><surname>Quackenbush</surname> <given-names>J</given-names></name><name><surname>Wahlestedt</surname> <given-names>C</given-names></name><name><surname>Mattick</surname> <given-names>JS</given-names></name><name><surname>Hume</surname> <given-names>DA</given-names></name><name><surname>Kai</surname> <given-names>C</given-names></name><name><surname>Sasaki</surname> <given-names>D</given-names></name><name><surname>Tomaru</surname> <given-names>Y</given-names></name><name><surname>Fukuda</surname> <given-names>S</given-names></name><name><surname>Kanamori-Katayama</surname> <given-names>M</given-names></name><name><surname>Suzuki</surname> <given-names>M</given-names></name><name><surname>Aoki</surname> <given-names>J</given-names></name><name><surname>Arakawa</surname> <given-names>T</given-names></name><name><surname>Iida</surname> <given-names>J</given-names></name><name><surname>Imamura</surname> <given-names>K</given-names></name><name><surname>Itoh</surname> <given-names>M</given-names></name><name><surname>Kato</surname> <given-names>T</given-names></name><name><surname>Kawaji</surname> <given-names>H</given-names></name><name><surname>Kawagashira</surname> <given-names>N</given-names></name><name><surname>Kawashima</surname> <given-names>T</given-names></name><name><surname>Kojima</surname> <given-names>M</given-names></name><name><surname>Kondo</surname> <given-names>S</given-names></name><name><surname>Konno</surname> <given-names>H</given-names></name><name><surname>Nakano</surname> <given-names>K</given-names></name><name><surname>Ninomiya</surname> <given-names>N</given-names></name><name><surname>Nishio</surname> <given-names>T</given-names></name><name><surname>Okada</surname> <given-names>M</given-names></name><name><surname>Plessy</surname> <given-names>C</given-names></name><name><surname>Shibata</surname> <given-names>K</given-names></name><name><surname>Shiraki</surname> <given-names>T</given-names></name><name><surname>Suzuki</surname> <given-names>S</given-names></name><name><surname>Tagami</surname> <given-names>M</given-names></name><name><surname>Waki</surname> <given-names>K</given-names></name><name><surname>Watahiki</surname> <given-names>A</given-names></name><name><surname>Okamura-Oho</surname> <given-names>Y</given-names></name><name><surname>Suzuki</surname> <given-names>H</given-names></name><name><surname>Kawai</surname> <given-names>J</given-names></name><name><surname>Hayashizaki</surname> <given-names>Y</given-names></name><collab>FANTOM Consortium</collab><collab>RIKEN Genome Exploration Research Group and Genome Science Group (Genome Network Project Core Group)</collab></person-group><year iso-8601-date="2005">2005</year><article-title>The transcriptional landscape of the mammalian genome</article-title><source>Science</source><volume>309</volume><fpage>1559</fpage><lpage>1563</lpage><pub-id pub-id-type="doi">10.1126/science.1112014</pub-id><pub-id pub-id-type="pmid">16141072</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>J</given-names></name><name><surname>Tu</surname> <given-names>X</given-names></name><name><surname>Esen</surname> <given-names>E</given-names></name><name><surname>Joeng</surname> <given-names>KS</given-names></name><name><surname>Lin</surname> <given-names>C</given-names></name><name><surname>Arbeit</surname> <given-names>JM</given-names></name><name><surname>Rüegg</surname> <given-names>MA</given-names></name><name><surname>Hall</surname> <given-names>MN</given-names></name><name><surname>Ma</surname> <given-names>L</given-names></name><name><surname>Long</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>WNT7B promotes bone formation in part through mTORC1</article-title><source>PLOS Genetics</source><volume>10</volume><elocation-id>e1004145</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1004145</pub-id><pub-id pub-id-type="pmid">24497849</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cipriano</surname> <given-names>A</given-names></name><name><surname>Ballarino</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The Ever-Evolving concept of the gene: the use of RNA/Protein experimental techniques to understand genome functions</article-title><source>Frontiers in Molecular Biosciences</source><volume>5</volume><elocation-id>20</elocation-id><pub-id pub-id-type="doi">10.3389/fmolb.2018.00020</pub-id><pub-id pub-id-type="pmid">29560353</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Desideri</surname> <given-names>F</given-names></name><name><surname>Cipriano</surname> <given-names>A</given-names></name><name><surname>Petrezselyova</surname> <given-names>S</given-names></name><name><surname>Buonaiuto</surname> <given-names>G</given-names></name><name><surname>Santini</surname> <given-names>T</given-names></name><name><surname>Kasparek</surname> <given-names>P</given-names></name><name><surname>Prochazka</surname> <given-names>J</given-names></name><name><surname>Janson</surname> <given-names>G</given-names></name><name><surname>Paiardini</surname> <given-names>A</given-names></name><name><surname>Calicchio</surname> <given-names>A</given-names></name><name><surname>Colantoni</surname> <given-names>A</given-names></name><name><surname>Sedlacek</surname> <given-names>R</given-names></name><name><surname>Bozzoni</surname> <given-names>I</given-names></name><name><surname>Ballarino</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Intronic determinants coordinate charme lncRNA nuclear activity through the interaction with MATR3 and PTBP1</article-title><source>Cell Reports</source><volume>33</volume><elocation-id>108548</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2020.108548</pub-id><pub-id pub-id-type="pmid">33357424</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dobin</surname> <given-names>A</given-names></name><name><surname>Davis</surname> <given-names>CA</given-names></name><name><surname>Schlesinger</surname> <given-names>F</given-names></name><name><surname>Drenkow</surname> <given-names>J</given-names></name><name><surname>Zaleski</surname> <given-names>C</given-names></name><name><surname>Jha</surname> <given-names>S</given-names></name><name><surname>Batut</surname> <given-names>P</given-names></name><name><surname>Chaisson</surname> <given-names>M</given-names></name><name><surname>Gingeras</surname> <given-names>TR</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>STAR: ultrafast universal RNA-seq aligner</article-title><source>Bioinformatics</source><volume>29</volume><fpage>15</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/bts635</pub-id><pub-id pub-id-type="pmid">23104886</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eden</surname> <given-names>E</given-names></name><name><surname>Navon</surname> <given-names>R</given-names></name><name><surname>Steinfeld</surname> <given-names>I</given-names></name><name><surname>Lipson</surname> <given-names>D</given-names></name><name><surname>Yakhini</surname> <given-names>Z</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists</article-title><source>BMC Bioinformatics</source><volume>10</volume><elocation-id>48</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2105-10-48</pub-id><pub-id pub-id-type="pmid">19192299</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eliazer</surname> <given-names>S</given-names></name><name><surname>Muncie</surname> <given-names>JM</given-names></name><name><surname>Christensen</surname> <given-names>J</given-names></name><name><surname>Sun</surname> <given-names>X</given-names></name><name><surname>D'Urso</surname> <given-names>RS</given-names></name><name><surname>Weaver</surname> <given-names>VM</given-names></name><name><surname>Brack</surname> <given-names>AS</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Wnt4 from the niche controls the Mechano-Properties and quiescent state of muscle stem cells</article-title><source>Cell Stem Cell</source><volume>25</volume><fpage>654</fpage><lpage>665</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2019.08.007</pub-id><pub-id pub-id-type="pmid">31495781</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Engreitz</surname> <given-names>JM</given-names></name><name><surname>Haines</surname> <given-names>JE</given-names></name><name><surname>Perez</surname> <given-names>EM</given-names></name><name><surname>Munson</surname> <given-names>G</given-names></name><name><surname>Chen</surname> <given-names>J</given-names></name><name><surname>Kane</surname> <given-names>M</given-names></name><name><surname>McDonel</surname> <given-names>PE</given-names></name><name><surname>Guttman</surname> <given-names>M</given-names></name><name><surname>Lander</surname> <given-names>ES</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Local regulation of gene expression by lncRNA promoters, transcription and splicing</article-title><source>Nature</source><volume>539</volume><fpage>452</fpage><lpage>455</lpage><pub-id pub-id-type="doi">10.1038/nature20149</pub-id><pub-id pub-id-type="pmid">27783602</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fatica</surname> <given-names>A</given-names></name><name><surname>Bozzoni</surname> <given-names>I</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Long non-coding RNAs: new players in cell differentiation and development</article-title><source>Nature Reviews Genetics</source><volume>15</volume><fpage>7</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1038/nrg3606</pub-id><pub-id pub-id-type="pmid">24296535</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Figeac</surname> <given-names>N</given-names></name><name><surname>Zammit</surname> <given-names>PS</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Coordinated action of Axin1 and Axin2 suppresses β-catenin to regulate muscle stem cell function</article-title><source>Cellular Signalling</source><volume>27</volume><fpage>1652</fpage><lpage>1665</lpage><pub-id pub-id-type="doi">10.1016/j.cellsig.2015.03.025</pub-id><pub-id pub-id-type="pmid">25866367</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname> <given-names>C-J</given-names></name><name><surname>Ma</surname> <given-names>X-K</given-names></name><name><surname>Xing</surname> <given-names>Y-H</given-names></name><name><surname>Zheng</surname> <given-names>C-C</given-names></name><name><surname>Xu</surname> <given-names>Y-F</given-names></name><name><surname>Shan</surname> <given-names>L</given-names></name><name><surname>Zhang</surname> <given-names>J</given-names></name><name><surname>Wang</surname> <given-names>S</given-names></name><name><surname>Wang</surname> <given-names>Y</given-names></name><name><surname>Carmichael</surname> <given-names>GG</given-names></name><name><surname>Yang</surname> <given-names>L</given-names></name><name><surname>Chen</surname> <given-names>L-L</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Distinct processing of lncRNAs contributes to Non-conserved functions in stem cells</article-title><source>Cell</source><volume>181</volume><fpage>621</fpage><lpage>636</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2020.03.006</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guttman</surname> <given-names>M</given-names></name><name><surname>Rinn</surname> <given-names>JL</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Modular regulatory principles of large non-coding RNAs</article-title><source>Nature</source><volume>482</volume><fpage>339</fpage><lpage>346</lpage><pub-id pub-id-type="doi">10.1038/nature10887</pub-id><pub-id pub-id-type="pmid">22337053</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname> <given-names>P</given-names></name><name><surname>Chu</surname> <given-names>J</given-names></name><name><surname>Wu</surname> <given-names>Y</given-names></name><name><surname>Sun</surname> <given-names>L</given-names></name><name><surname>Lv</surname> <given-names>X</given-names></name><name><surname>Zhu</surname> <given-names>Y</given-names></name><name><surname>Li</surname> <given-names>J</given-names></name><name><surname>Guo</surname> <given-names>Q</given-names></name><name><surname>Gong</surname> <given-names>C</given-names></name><name><surname>Liu</surname> <given-names>B</given-names></name><name><surname>Su</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>NBAT1 suppresses breast Cancer metastasis by regulating DKK1 via PRC2</article-title><source>Oncotarget</source><volume>6</volume><fpage>32410</fpage><lpage>32425</lpage><pub-id pub-id-type="doi">10.18632/oncotarget.5609</pub-id><pub-id pub-id-type="pmid">26378045</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huarte</surname> <given-names>M</given-names></name><name><surname>Guttman</surname> <given-names>M</given-names></name><name><surname>Feldser</surname> <given-names>D</given-names></name><name><surname>Garber</surname> <given-names>M</given-names></name><name><surname>Koziol</surname> <given-names>MJ</given-names></name><name><surname>Kenzelmann-Broz</surname> <given-names>D</given-names></name><name><surname>Khalil</surname> <given-names>AM</given-names></name><name><surname>Zuk</surname> <given-names>O</given-names></name><name><surname>Amit</surname> <given-names>I</given-names></name><name><surname>Rabani</surname> <given-names>M</given-names></name><name><surname>Attardi</surname> <given-names>LD</given-names></name><name><surname>Regev</surname> <given-names>A</given-names></name><name><surname>Lander</surname> <given-names>ES</given-names></name><name><surname>Jacks</surname> <given-names>T</given-names></name><name><surname>Rinn</surname> <given-names>JL</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response</article-title><source>Cell</source><volume>142</volume><fpage>409</fpage><lpage>419</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2010.06.040</pub-id><pub-id pub-id-type="pmid">20673990</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khalil</surname> <given-names>AM</given-names></name><name><surname>Guttman</surname> <given-names>M</given-names></name><name><surname>Huarte</surname> <given-names>M</given-names></name><name><surname>Garber</surname> <given-names>M</given-names></name><name><surname>Raj</surname> <given-names>A</given-names></name><name><surname>Rivea Morales</surname> <given-names>D</given-names></name><name><surname>Thomas</surname> <given-names>K</given-names></name><name><surname>Presser</surname> <given-names>A</given-names></name><name><surname>Bernstein</surname> <given-names>BE</given-names></name><name><surname>van Oudenaarden</surname> <given-names>A</given-names></name><name><surname>Regev</surname> <given-names>A</given-names></name><name><surname>Lander</surname> <given-names>ES</given-names></name><name><surname>Rinn</surname> <given-names>JL</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression</article-title><source>PNAS</source><volume>106</volume><fpage>11667</fpage><lpage>11672</lpage><pub-id pub-id-type="doi">10.1073/pnas.0904715106</pub-id><pub-id pub-id-type="pmid">19571010</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kopp</surname> <given-names>F</given-names></name><name><surname>Mendell</surname> <given-names>JT</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Functional classification and experimental dissection of long noncoding RNAs</article-title><source>Cell</source><volume>172</volume><fpage>393</fpage><lpage>407</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2018.01.011</pub-id><pub-id pub-id-type="pmid">29373828</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lacour</surname> <given-names>F</given-names></name><name><surname>Vezin</surname> <given-names>E</given-names></name><name><surname>Bentzinger</surname> <given-names>CF</given-names></name><name><surname>Sincennes</surname> <given-names>MC</given-names></name><name><surname>Giordani</surname> <given-names>L</given-names></name><name><surname>Ferry</surname> <given-names>A</given-names></name><name><surname>Mitchell</surname> <given-names>R</given-names></name><name><surname>Patel</surname> <given-names>K</given-names></name><name><surname>Rudnicki</surname> <given-names>MA</given-names></name><name><surname>Chaboissier</surname> <given-names>MC</given-names></name><name><surname>Chassot</surname> <given-names>AA</given-names></name><name><surname>Le Grand</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>R-spondin1 controls muscle cell fusion through dual regulation of antagonistic wnt signaling pathways</article-title><source>Cell Reports</source><volume>18</volume><fpage>2320</fpage><lpage>2330</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2017.02.036</pub-id><pub-id pub-id-type="pmid">28273449</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Le Grand</surname> <given-names>F</given-names></name><name><surname>Jones</surname> <given-names>AE</given-names></name><name><surname>Seale</surname> <given-names>V</given-names></name><name><surname>Scimè</surname> <given-names>A</given-names></name><name><surname>Rudnicki</surname> <given-names>MA</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Wnt7a activates the planar cell polarity pathway to drive the symmetric expansion of satellite stem cells</article-title><source>Cell Stem Cell</source><volume>4</volume><fpage>535</fpage><lpage>547</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2009.03.013</pub-id><pub-id pub-id-type="pmid">19497282</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Legnini</surname> <given-names>I</given-names></name><name><surname>Di Timoteo</surname> <given-names>G</given-names></name><name><surname>Rossi</surname> <given-names>F</given-names></name><name><surname>Morlando</surname> <given-names>M</given-names></name><name><surname>Briganti</surname> <given-names>F</given-names></name><name><surname>Sthandier</surname> <given-names>O</given-names></name><name><surname>Fatica</surname> <given-names>A</given-names></name><name><surname>Santini</surname> <given-names>T</given-names></name><name><surname>Andronache</surname> <given-names>A</given-names></name><name><surname>Wade</surname> <given-names>M</given-names></name><name><surname>Laneve</surname> <given-names>P</given-names></name><name><surname>Rajewsky</surname> <given-names>N</given-names></name><name><surname>Bozzoni</surname> <given-names>I</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Circ-ZNF609 is a circular RNA that can be translated and functions in myogenesis</article-title><source>Molecular Cell</source><volume>66</volume><fpage>22</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2017.02.017</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ling</surname> <given-names>BM</given-names></name><name><surname>Bharathy</surname> <given-names>N</given-names></name><name><surname>Chung</surname> <given-names>TK</given-names></name><name><surname>Kok</surname> <given-names>WK</given-names></name><name><surname>Li</surname> <given-names>S</given-names></name><name><surname>Tan</surname> <given-names>YH</given-names></name><name><surname>Rao</surname> <given-names>VK</given-names></name><name><surname>Gopinadhan</surname> <given-names>S</given-names></name><name><surname>Sartorelli</surname> <given-names>V</given-names></name><name><surname>Walsh</surname> <given-names>MJ</given-names></name><name><surname>Taneja</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Lysine methyltransferase G9a methylates the transcription factor MyoD and regulates skeletal muscle differentiation</article-title><source>PNAS</source><volume>109</volume><fpage>841</fpage><lpage>846</lpage><pub-id pub-id-type="doi">10.1073/pnas.1111628109</pub-id><pub-id pub-id-type="pmid">22215600</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname> <given-names>L</given-names></name><name><surname>Sun</surname> <given-names>K</given-names></name><name><surname>Chen</surname> <given-names>X</given-names></name><name><surname>Zhao</surname> <given-names>Y</given-names></name><name><surname>Wang</surname> <given-names>L</given-names></name><name><surname>Zhou</surname> <given-names>L</given-names></name><name><surname>Sun</surname> <given-names>H</given-names></name><name><surname>Wang</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Genome-wide survey by ChIP-seq reveals YY1 regulation of lincRNAs in skeletal myogenesis</article-title><source>The EMBO Journal</source><volume>32</volume><fpage>2575</fpage><lpage>2588</lpage><pub-id pub-id-type="doi">10.1038/emboj.2013.182</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maamar</surname> <given-names>H</given-names></name><name><surname>Cabili</surname> <given-names>MN</given-names></name><name><surname>Rinn</surname> <given-names>J</given-names></name><name><surname>Raj</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>linc-HOXA1 is a noncoding RNA that represses Hoxa1 transcription in Cis</article-title><source>Genes &amp; Development</source><volume>27</volume><fpage>1260</fpage><lpage>1271</lpage><pub-id pub-id-type="doi">10.1101/gad.217018.113</pub-id><pub-id pub-id-type="pmid">23723417</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McHugh</surname> <given-names>CA</given-names></name><name><surname>Chen</surname> <given-names>CK</given-names></name><name><surname>Chow</surname> <given-names>A</given-names></name><name><surname>Surka</surname> <given-names>CF</given-names></name><name><surname>Tran</surname> <given-names>C</given-names></name><name><surname>McDonel</surname> <given-names>P</given-names></name><name><surname>Pandya-Jones</surname> <given-names>A</given-names></name><name><surname>Blanco</surname> <given-names>M</given-names></name><name><surname>Burghard</surname> <given-names>C</given-names></name><name><surname>Moradian</surname> <given-names>A</given-names></name><name><surname>Sweredoski</surname> <given-names>MJ</given-names></name><name><surname>Shishkin</surname> <given-names>AA</given-names></name><name><surname>Su</surname> <given-names>J</given-names></name><name><surname>Lander</surname> <given-names>ES</given-names></name><name><surname>Hess</surname> <given-names>S</given-names></name><name><surname>Plath</surname> <given-names>K</given-names></name><name><surname>Guttman</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The xist lncRNA interacts directly with SHARP to silence transcription through HDAC3</article-title><source>Nature</source><volume>521</volume><fpage>232</fpage><lpage>236</lpage><pub-id pub-id-type="doi">10.1038/nature14443</pub-id><pub-id pub-id-type="pmid">25915022</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mozzetta</surname> <given-names>C</given-names></name><name><surname>Pontis</surname> <given-names>J</given-names></name><name><surname>Fritsch</surname> <given-names>L</given-names></name><name><surname>Robin</surname> <given-names>P</given-names></name><name><surname>Portoso</surname> <given-names>M</given-names></name><name><surname>Proux</surname> <given-names>C</given-names></name><name><surname>Margueron</surname> <given-names>R</given-names></name><name><surname>Ait-Si-Ali</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The histone H3 lysine 9 methyltransferases G9a and GLP regulate polycomb repressive complex 2-mediated gene silencing</article-title><source>Molecular Cell</source><volume>53</volume><fpage>277</fpage><lpage>289</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2013.12.005</pub-id><pub-id pub-id-type="pmid">24389103</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mozzetta</surname> <given-names>C</given-names></name><name><surname>Boyarchuk</surname> <given-names>E</given-names></name><name><surname>Pontis</surname> <given-names>J</given-names></name><name><surname>Ait-Si-Ali</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Sound of silence: the properties and functions of repressive lys methyltransferases</article-title><source>Nature Reviews Molecular Cell Biology</source><volume>16</volume><fpage>499</fpage><lpage>513</lpage><pub-id pub-id-type="doi">10.1038/nrm4029</pub-id><pub-id pub-id-type="pmid">26204160</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mozzetta</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Isolation and culture of muscle stem cells</article-title><source>Jove</source><volume>1480</volume><elocation-id>50846</elocation-id><pub-id pub-id-type="doi">10.3791/50846</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagano</surname> <given-names>T</given-names></name><name><surname>Mitchell</surname> <given-names>JA</given-names></name><name><surname>Sanz</surname> <given-names>LA</given-names></name><name><surname>Pauler</surname> <given-names>FM</given-names></name><name><surname>Ferguson-Smith</surname> <given-names>AC</given-names></name><name><surname>Feil</surname> <given-names>R</given-names></name><name><surname>Fraser</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>The air noncoding RNA epigenetically silences transcription by targeting G9a to chromatin</article-title><source>Science</source><volume>322</volume><fpage>1717</fpage><lpage>1720</lpage><pub-id pub-id-type="doi">10.1126/science.1163802</pub-id><pub-id pub-id-type="pmid">18988810</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noguchi</surname> <given-names>S</given-names></name><name><surname>Arakawa</surname> <given-names>T</given-names></name><name><surname>Fukuda</surname> <given-names>S</given-names></name><name><surname>Furuno</surname> <given-names>M</given-names></name><name><surname>Hasegawa</surname> <given-names>A</given-names></name><name><surname>Hori</surname> <given-names>F</given-names></name><name><surname>Ishikawa-Kato</surname> <given-names>S</given-names></name><name><surname>Kaida</surname> <given-names>K</given-names></name><name><surname>Kaiho</surname> <given-names>A</given-names></name><name><surname>Kanamori-Katayama</surname> <given-names>M</given-names></name><name><surname>Kawashima</surname> <given-names>T</given-names></name><name><surname>Kojima</surname> <given-names>M</given-names></name><name><surname>Kubosaki</surname> <given-names>A</given-names></name><name><surname>Manabe</surname> <given-names>RI</given-names></name><name><surname>Murata</surname> <given-names>M</given-names></name><name><surname>Nagao-Sato</surname> <given-names>S</given-names></name><name><surname>Nakazato</surname> <given-names>K</given-names></name><name><surname>Ninomiya</surname> <given-names>N</given-names></name><name><surname>Nishiyori-Sueki</surname> <given-names>H</given-names></name><name><surname>Noma</surname> <given-names>S</given-names></name><name><surname>Saijyo</surname> <given-names>E</given-names></name><name><surname>Saka</surname> <given-names>A</given-names></name><name><surname>Sakai</surname> <given-names>M</given-names></name><name><surname>Simon</surname> <given-names>C</given-names></name><name><surname>Suzuki</surname> <given-names>N</given-names></name><name><surname>Tagami</surname> <given-names>M</given-names></name><name><surname>Watanabe</surname> <given-names>S</given-names></name><name><surname>Yoshida</surname> <given-names>S</given-names></name><name><surname>Arner</surname> <given-names>P</given-names></name><name><surname>Axton</surname> <given-names>RA</given-names></name><name><surname>Babina</surname> <given-names>M</given-names></name><name><surname>Baillie</surname> <given-names>JK</given-names></name><name><surname>Barnett</surname> <given-names>TC</given-names></name><name><surname>Beckhouse</surname> <given-names>AG</given-names></name><name><surname>Blumenthal</surname> <given-names>A</given-names></name><name><surname>Bodega</surname> <given-names>B</given-names></name><name><surname>Bonetti</surname> <given-names>A</given-names></name><name><surname>Briggs</surname> <given-names>J</given-names></name><name><surname>Brombacher</surname> <given-names>F</given-names></name><name><surname>Carlisle</surname> <given-names>AJ</given-names></name><name><surname>Clevers</surname> <given-names>HC</given-names></name><name><surname>Davis</surname> <given-names>CA</given-names></name><name><surname>Detmar</surname> <given-names>M</given-names></name><name><surname>Dohi</surname> <given-names>T</given-names></name><name><surname>Edge</surname> <given-names>ASB</given-names></name><name><surname>Edinger</surname> <given-names>M</given-names></name><name><surname>Ehrlund</surname> <given-names>A</given-names></name><name><surname>Ekwall</surname> <given-names>K</given-names></name><name><surname>Endoh</surname> <given-names>M</given-names></name><name><surname>Enomoto</surname> <given-names>H</given-names></name><name><surname>Eslami</surname> <given-names>A</given-names></name><name><surname>Fagiolini</surname> <given-names>M</given-names></name><name><surname>Fairbairn</surname> <given-names>L</given-names></name><name><surname>Farach-Carson</surname> <given-names>MC</given-names></name><name><surname>Faulkner</surname> <given-names>GJ</given-names></name><name><surname>Ferrai</surname> <given-names>C</given-names></name><name><surname>Fisher</surname> <given-names>ME</given-names></name><name><surname>Forrester</surname> <given-names>LM</given-names></name><name><surname>Fujita</surname> <given-names>R</given-names></name><name><surname>Furusawa</surname> <given-names>JI</given-names></name><name><surname>Geijtenbeek</surname> <given-names>TB</given-names></name><name><surname>Gingeras</surname> <given-names>T</given-names></name><name><surname>Goldowitz</surname> <given-names>D</given-names></name><name><surname>Guhl</surname> <given-names>S</given-names></name><name><surname>Guler</surname> <given-names>R</given-names></name><name><surname>Gustincich</surname> <given-names>S</given-names></name><name><surname>Ha</surname> <given-names>TJ</given-names></name><name><surname>Hamaguchi</surname> <given-names>M</given-names></name><name><surname>Hara</surname> <given-names>M</given-names></name><name><surname>Hasegawa</surname> <given-names>Y</given-names></name><name><surname>Herlyn</surname> <given-names>M</given-names></name><name><surname>Heutink</surname> <given-names>P</given-names></name><name><surname>Hitchens</surname> <given-names>KJ</given-names></name><name><surname>Hume</surname> <given-names>DA</given-names></name><name><surname>Ikawa</surname> <given-names>T</given-names></name><name><surname>Ishizu</surname> <given-names>Y</given-names></name><name><surname>Kai</surname> <given-names>C</given-names></name><name><surname>Kawamoto</surname> <given-names>H</given-names></name><name><surname>Kawamura</surname> <given-names>YI</given-names></name><name><surname>Kempfle</surname> <given-names>JS</given-names></name><name><surname>Kenna</surname> <given-names>TJ</given-names></name><name><surname>Kere</surname> <given-names>J</given-names></name><name><surname>Khachigian</surname> <given-names>LM</given-names></name><name><surname>Kitamura</surname> <given-names>T</given-names></name><name><surname>Klein</surname> <given-names>S</given-names></name><name><surname>Klinken</surname> <given-names>SP</given-names></name><name><surname>Knox</surname> <given-names>AJ</given-names></name><name><surname>Kojima</surname> <given-names>S</given-names></name><name><surname>Koseki</surname> <given-names>H</given-names></name><name><surname>Koyasu</surname> <given-names>S</given-names></name><name><surname>Lee</surname> <given-names>W</given-names></name><name><surname>Lennartsson</surname> <given-names>A</given-names></name><name><surname>Mackay-Sim</surname> <given-names>A</given-names></name><name><surname>Mejhert</surname> <given-names>N</given-names></name><name><surname>Mizuno</surname> <given-names>Y</given-names></name><name><surname>Morikawa</surname> <given-names>H</given-names></name><name><surname>Morimoto</surname> <given-names>M</given-names></name><name><surname>Moro</surname> <given-names>K</given-names></name><name><surname>Morris</surname> <given-names>KJ</given-names></name><name><surname>Motohashi</surname> <given-names>H</given-names></name><name><surname>Mummery</surname> <given-names>CL</given-names></name><name><surname>Nakachi</surname> <given-names>Y</given-names></name><name><surname>Nakahara</surname> <given-names>F</given-names></name><name><surname>Nakamura</surname> <given-names>T</given-names></name><name><surname>Nakamura</surname> <given-names>Y</given-names></name><name><surname>Nozaki</surname> <given-names>T</given-names></name><name><surname>Ogishima</surname> <given-names>S</given-names></name><name><surname>Ohkura</surname> <given-names>N</given-names></name><name><surname>Ohno</surname> <given-names>H</given-names></name><name><surname>Ohshima</surname> <given-names>M</given-names></name><name><surname>Okada-Hatakeyama</surname> <given-names>M</given-names></name><name><surname>Okazaki</surname> <given-names>Y</given-names></name><name><surname>Orlando</surname> <given-names>V</given-names></name><name><surname>Ovchinnikov</surname> <given-names>DA</given-names></name><name><surname>Passier</surname> <given-names>R</given-names></name><name><surname>Patrikakis</surname> <given-names>M</given-names></name><name><surname>Pombo</surname> <given-names>A</given-names></name><name><surname>Pradhan-Bhatt</surname> <given-names>S</given-names></name><name><surname>Qin</surname> <given-names>XY</given-names></name><name><surname>Rehli</surname> <given-names>M</given-names></name><name><surname>Rizzu</surname> <given-names>P</given-names></name><name><surname>Roy</surname> <given-names>S</given-names></name><name><surname>Sajantila</surname> <given-names>A</given-names></name><name><surname>Sakaguchi</surname> <given-names>S</given-names></name><name><surname>Sato</surname> <given-names>H</given-names></name><name><surname>Satoh</surname> <given-names>H</given-names></name><name><surname>Savvi</surname> <given-names>S</given-names></name><name><surname>Saxena</surname> <given-names>A</given-names></name><name><surname>Schmidl</surname> <given-names>C</given-names></name><name><surname>Schneider</surname> <given-names>C</given-names></name><name><surname>Schulze-Tanzil</surname> <given-names>GG</given-names></name><name><surname>Schwegmann</surname> <given-names>A</given-names></name><name><surname>Sheng</surname> <given-names>G</given-names></name><name><surname>Shin</surname> <given-names>JW</given-names></name><name><surname>Sugiyama</surname> <given-names>D</given-names></name><name><surname>Sugiyama</surname> <given-names>T</given-names></name><name><surname>Summers</surname> <given-names>KM</given-names></name><name><surname>Takahashi</surname> <given-names>N</given-names></name><name><surname>Takai</surname> <given-names>J</given-names></name><name><surname>Tanaka</surname> <given-names>H</given-names></name><name><surname>Tatsukawa</surname> <given-names>H</given-names></name><name><surname>Tomoiu</surname> <given-names>A</given-names></name><name><surname>Toyoda</surname> <given-names>H</given-names></name><name><surname>van de Wetering</surname> <given-names>M</given-names></name><name><surname>van den Berg</surname> <given-names>LM</given-names></name><name><surname>Verardo</surname> <given-names>R</given-names></name><name><surname>Vijayan</surname> <given-names>D</given-names></name><name><surname>Wells</surname> <given-names>CA</given-names></name><name><surname>Winteringham</surname> <given-names>LN</given-names></name><name><surname>Wolvetang</surname> <given-names>E</given-names></name><name><surname>Yamaguchi</surname> <given-names>Y</given-names></name><name><surname>Yamamoto</surname> <given-names>M</given-names></name><name><surname>Yanagi-Mizuochi</surname> <given-names>C</given-names></name><name><surname>Yoneda</surname> <given-names>M</given-names></name><name><surname>Yonekura</surname> <given-names>Y</given-names></name><name><surname>Zhang</surname> <given-names>PG</given-names></name><name><surname>Zucchelli</surname> <given-names>S</given-names></name><name><surname>Abugessaisa</surname> <given-names>I</given-names></name><name><surname>Arner</surname> <given-names>E</given-names></name><name><surname>Harshbarger</surname> <given-names>J</given-names></name><name><surname>Kondo</surname> <given-names>A</given-names></name><name><surname>Lassmann</surname> <given-names>T</given-names></name><name><surname>Lizio</surname> <given-names>M</given-names></name><name><surname>Sahin</surname> <given-names>S</given-names></name><name><surname>Sengstag</surname> <given-names>T</given-names></name><name><surname>Severin</surname> <given-names>J</given-names></name><name><surname>Shimoji</surname> <given-names>H</given-names></name><name><surname>Suzuki</surname> <given-names>M</given-names></name><name><surname>Suzuki</surname> <given-names>H</given-names></name><name><surname>Kawai</surname> <given-names>J</given-names></name><name><surname>Kondo</surname> <given-names>N</given-names></name><name><surname>Itoh</surname> <given-names>M</given-names></name><name><surname>Daub</surname> <given-names>CO</given-names></name><name><surname>Kasukawa</surname> <given-names>T</given-names></name><name><surname>Kawaji</surname> <given-names>H</given-names></name><name><surname>Carninci</surname> <given-names>P</given-names></name><name><surname>Forrest</surname> <given-names>ARR</given-names></name><name><surname>Hayashizaki</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>FANTOM5 CAGE profiles of human and mouse samples</article-title><source>Scientific Data</source><volume>4</volume><elocation-id>170112</elocation-id><pub-id pub-id-type="doi">10.1038/sdata.2017.112</pub-id><pub-id pub-id-type="pmid">28850106</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nusse</surname> <given-names>R</given-names></name><name><surname>Clevers</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Wnt/β-Catenin signaling, disease, and emerging therapeutic modalities</article-title><source>Cell</source><volume>169</volume><fpage>985</fpage><lpage>999</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2017.05.016</pub-id><pub-id pub-id-type="pmid">28575679</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ong</surname> <given-names>MS</given-names></name><name><surname>Cai</surname> <given-names>W</given-names></name><name><surname>Yuan</surname> <given-names>Y</given-names></name><name><surname>Leong</surname> <given-names>HC</given-names></name><name><surname>Tan</surname> <given-names>TZ</given-names></name><name><surname>Mohammad</surname> <given-names>A</given-names></name><name><surname>You</surname> <given-names>ML</given-names></name><name><surname>Arfuso</surname> <given-names>F</given-names></name><name><surname>Goh</surname> <given-names>BC</given-names></name><name><surname>Warrier</surname> <given-names>S</given-names></name><name><surname>Sethi</surname> <given-names>G</given-names></name><name><surname>Tolwinski</surname> <given-names>NS</given-names></name><name><surname>Lobie</surname> <given-names>PE</given-names></name><name><surname>Yap</surname> <given-names>CT</given-names></name><name><surname>Hooi</surname> <given-names>SC</given-names></name><name><surname>Huang</surname> <given-names>RY</given-names></name><name><surname>Kumar</surname> <given-names>AP</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>'Lnc'-ing Wnt in female reproductive cancers: therapeutic potential of long non-coding RNAs in Wnt signalling</article-title><source>British Journal of Pharmacology</source><volume>174</volume><fpage>4684</fpage><lpage>4700</lpage><pub-id pub-id-type="doi">10.1111/bph.13958</pub-id><pub-id pub-id-type="pmid">28736855</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pandey</surname> <given-names>RR</given-names></name><name><surname>Mondal</surname> <given-names>T</given-names></name><name><surname>Mohammad</surname> <given-names>F</given-names></name><name><surname>Enroth</surname> <given-names>S</given-names></name><name><surname>Redrup</surname> <given-names>L</given-names></name><name><surname>Komorowski</surname> <given-names>J</given-names></name><name><surname>Nagano</surname> <given-names>T</given-names></name><name><surname>Mancini-Dinardo</surname> <given-names>D</given-names></name><name><surname>Kanduri</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Kcnq1ot1 antisense noncoding RNA mediates lineage-specific transcriptional silencing through chromatin-level regulation</article-title><source>Molecular Cell</source><volume>32</volume><fpage>232</fpage><lpage>246</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2008.08.022</pub-id><pub-id pub-id-type="pmid">18951091</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parisi</surname> <given-names>A</given-names></name><name><surname>Lacour</surname> <given-names>F</given-names></name><name><surname>Giordani</surname> <given-names>L</given-names></name><name><surname>Colnot</surname> <given-names>S</given-names></name><name><surname>Maire</surname> <given-names>P</given-names></name><name><surname>Le Grand</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>APC is required for muscle stem cell proliferation and skeletal muscle tissue repair</article-title><source>Journal of Cell Biology</source><volume>210</volume><fpage>717</fpage><lpage>726</lpage><pub-id pub-id-type="doi">10.1083/jcb.201501053</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Polesskaya</surname> <given-names>A</given-names></name><name><surname>Seale</surname> <given-names>P</given-names></name><name><surname>Rudnicki</surname> <given-names>MA</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Wnt signaling induces the myogenic specification of resident CD45+ adult stem cells during muscle regeneration</article-title><source>Cell</source><volume>113</volume><fpage>841</fpage><lpage>852</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(03)00437-9</pub-id><pub-id pub-id-type="pmid">12837243</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rinn</surname> <given-names>JL</given-names></name><name><surname>Kertesz</surname> <given-names>M</given-names></name><name><surname>Wang</surname> <given-names>JK</given-names></name><name><surname>Squazzo</surname> <given-names>SL</given-names></name><name><surname>Xu</surname> <given-names>X</given-names></name><name><surname>Brugmann</surname> <given-names>SA</given-names></name><name><surname>Goodnough</surname> <given-names>LH</given-names></name><name><surname>Helms</surname> <given-names>JA</given-names></name><name><surname>Farnham</surname> <given-names>PJ</given-names></name><name><surname>Segal</surname> <given-names>E</given-names></name><name><surname>Chang</surname> <given-names>HY</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs</article-title><source>Cell</source><volume>129</volume><fpage>1311</fpage><lpage>1323</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2007.05.022</pub-id><pub-id pub-id-type="pmid">17604720</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rinn</surname> <given-names>JL</given-names></name><name><surname>Chang</surname> <given-names>HY</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Genome regulation by long noncoding RNAs</article-title><source>Annual Review of Biochemistry</source><volume>81</volume><fpage>145</fpage><lpage>166</lpage><pub-id pub-id-type="doi">10.1146/annurev-biochem-051410-092902</pub-id><pub-id pub-id-type="pmid">22663078</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname> <given-names>JT</given-names></name><name><surname>Thorvaldsdóttir</surname> <given-names>H</given-names></name><name><surname>Winckler</surname> <given-names>W</given-names></name><name><surname>Guttman</surname> <given-names>M</given-names></name><name><surname>Lander</surname> <given-names>ES</given-names></name><name><surname>Getz</surname> <given-names>G</given-names></name><name><surname>Mesirov</surname> <given-names>JP</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Integrative genomics viewer</article-title><source>Nature Biotechnology</source><volume>29</volume><fpage>24</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1038/nbt.1754</pub-id><pub-id pub-id-type="pmid">21221095</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rossi</surname> <given-names>F</given-names></name><name><surname>Legnini</surname> <given-names>I</given-names></name><name><surname>Megiorni</surname> <given-names>F</given-names></name><name><surname>Colantoni</surname> <given-names>A</given-names></name><name><surname>Santini</surname> <given-names>T</given-names></name><name><surname>Morlando</surname> <given-names>M</given-names></name><name><surname>Di Timoteo</surname> <given-names>G</given-names></name><name><surname>Dattilo</surname> <given-names>D</given-names></name><name><surname>Dominici</surname> <given-names>C</given-names></name><name><surname>Bozzoni</surname> <given-names>I</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Circ-ZNF609 regulates G1-S progression in Rhabdomyosarcoma</article-title><source>Oncogene</source><volume>38</volume><fpage>3843</fpage><lpage>3854</lpage><pub-id pub-id-type="doi">10.1038/s41388-019-0699-4</pub-id><pub-id pub-id-type="pmid">30670781</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rudolf</surname> <given-names>A</given-names></name><name><surname>Schirwis</surname> <given-names>E</given-names></name><name><surname>Giordani</surname> <given-names>L</given-names></name><name><surname>Parisi</surname> <given-names>A</given-names></name><name><surname>Lepper</surname> <given-names>C</given-names></name><name><surname>Taketo</surname> <given-names>MM</given-names></name><name><surname>Le Grand</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>β-Catenin activation in muscle progenitor cells regulates tissue repair</article-title><source>Cell Reports</source><volume>15</volume><fpage>1277</fpage><lpage>1290</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2016.04.022</pub-id><pub-id pub-id-type="pmid">27134174</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santini</surname> <given-names>T</given-names></name><name><surname>Martone</surname> <given-names>J</given-names></name><name><surname>Ballarino</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Visualization of nuclear and cytoplasmic long noncoding RNAs at Single-Cell level by RNA-FISH</article-title><source>Methods in Molecular Biology</source><volume>2157</volume><fpage>251</fpage><lpage>280</lpage><pub-id pub-id-type="doi">10.1007/978-1-0716-0664-3_15</pub-id><pub-id pub-id-type="pmid">32820409</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname> <given-names>P</given-names></name><name><surname>Pichler</surname> <given-names>M</given-names></name><name><surname>Chen</surname> <given-names>M</given-names></name><name><surname>Calin</surname> <given-names>G</given-names></name><name><surname>Ling</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>To wnt or lose: the missing Non-Coding linc in colorectal Cancer</article-title><source>International Journal of Molecular Sciences</source><volume>18</volume><elocation-id>2003</elocation-id><pub-id pub-id-type="doi">10.3390/ijms18092003</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname> <given-names>Q</given-names></name><name><surname>Hao</surname> <given-names>Q</given-names></name><name><surname>Prasanth</surname> <given-names>KV</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Nuclear long noncoding RNAs: key regulators of gene expression</article-title><source>Trends in Genetics</source><volume>34</volume><fpage>142</fpage><lpage>157</lpage><pub-id pub-id-type="doi">10.1016/j.tig.2017.11.005</pub-id><pub-id pub-id-type="pmid">29249332</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ulitsky</surname> <given-names>I</given-names></name><name><surname>Bartel</surname> <given-names>DP</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>lincRNAs: genomics, evolution, and mechanisms</article-title><source>Cell</source><volume>154</volume><fpage>26</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2013.06.020</pub-id><pub-id pub-id-type="pmid">23827673</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>von Maltzahn</surname> <given-names>J</given-names></name><name><surname>Chang</surname> <given-names>NC</given-names></name><name><surname>Bentzinger</surname> <given-names>CF</given-names></name><name><surname>Rudnicki</surname> <given-names>MA</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Wnt signaling in myogenesis</article-title><source>Trends in Cell Biology</source><volume>22</volume><fpage>602</fpage><lpage>609</lpage><pub-id pub-id-type="doi">10.1016/j.tcb.2012.07.008</pub-id><pub-id pub-id-type="pmid">22944199</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>Z</given-names></name><name><surname>Shu</surname> <given-names>W</given-names></name><name><surname>Lu</surname> <given-names>MM</given-names></name><name><surname>Morrisey</surname> <given-names>EE</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Wnt7b activates canonical signaling in epithelial and vascular smooth muscle cells through interactions with Fzd1, Fzd10, and LRP5</article-title><source>Molecular and Cellular Biology</source><volume>25</volume><fpage>5022</fpage><lpage>5030</lpage><pub-id pub-id-type="doi">10.1128/MCB.25.12.5022-5030.2005</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>KC</given-names></name><name><surname>Yang</surname> <given-names>YW</given-names></name><name><surname>Liu</surname> <given-names>B</given-names></name><name><surname>Sanyal</surname> <given-names>A</given-names></name><name><surname>Corces-Zimmerman</surname> <given-names>R</given-names></name><name><surname>Chen</surname> <given-names>Y</given-names></name><name><surname>Lajoie</surname> <given-names>BR</given-names></name><name><surname>Protacio</surname> <given-names>A</given-names></name><name><surname>Flynn</surname> <given-names>RA</given-names></name><name><surname>Gupta</surname> <given-names>RA</given-names></name><name><surname>Wysocka</surname> <given-names>J</given-names></name><name><surname>Lei</surname> <given-names>M</given-names></name><name><surname>Dekker</surname> <given-names>J</given-names></name><name><surname>Helms</surname> <given-names>JA</given-names></name><name><surname>Chang</surname> <given-names>HY</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression</article-title><source>Nature</source><volume>472</volume><fpage>120</fpage><lpage>124</lpage><pub-id pub-id-type="doi">10.1038/nature09819</pub-id><pub-id pub-id-type="pmid">21423168</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>L</given-names></name><name><surname>Zhao</surname> <given-names>Y</given-names></name><name><surname>Bao</surname> <given-names>X</given-names></name><name><surname>Zhu</surname> <given-names>X</given-names></name><name><surname>Kwok</surname> <given-names>YK</given-names></name><name><surname>Sun</surname> <given-names>K</given-names></name><name><surname>Chen</surname> <given-names>X</given-names></name><name><surname>Huang</surname> <given-names>Y</given-names></name><name><surname>Jauch</surname> <given-names>R</given-names></name><name><surname>Esteban</surname> <given-names>MA</given-names></name><name><surname>Sun</surname> <given-names>H</given-names></name><name><surname>Wang</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>LncRNA dum interacts with dnmts to regulate Dppa2 expression during myogenic differentiation and muscle regeneration</article-title><source>Cell Research</source><volume>25</volume><fpage>335</fpage><lpage>350</lpage><pub-id pub-id-type="doi">10.1038/cr.2015.21</pub-id><pub-id pub-id-type="pmid">25686699</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zarkou</surname> <given-names>V</given-names></name><name><surname>Galaras</surname> <given-names>A</given-names></name><name><surname>Giakountis</surname> <given-names>A</given-names></name><name><surname>Hatzis</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Crosstalk mechanisms between the WNT signaling pathway and long non-coding RNAs</article-title><source>Non-Coding RNA Research</source><volume>3</volume><fpage>42</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1016/j.ncrna.2018.04.001</pub-id><pub-id pub-id-type="pmid">30159439</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname> <given-names>J</given-names></name><name><surname>Sun</surname> <given-names>BK</given-names></name><name><surname>Erwin</surname> <given-names>JA</given-names></name><name><surname>Song</surname> <given-names>JJ</given-names></name><name><surname>Lee</surname> <given-names>JT</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Polycomb proteins targeted by a short repeat RNA to the mouse X chromosome</article-title><source>Science</source><volume>322</volume><fpage>750</fpage><lpage>756</lpage><pub-id pub-id-type="doi">10.1126/science.1163045</pub-id><pub-id pub-id-type="pmid">18974356</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname> <given-names>Y</given-names></name><name><surname>Chen</surname> <given-names>M</given-names></name><name><surname>Lian</surname> <given-names>Z</given-names></name><name><surname>Li</surname> <given-names>Y</given-names></name><name><surname>Li</surname> <given-names>Y</given-names></name><name><surname>Wang</surname> <given-names>J</given-names></name><name><surname>Deng</surname> <given-names>S</given-names></name><name><surname>Kun</surname> <given-names>Y</given-names></name><name><surname>Lian</surname> <given-names>Z</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Non-Coding RNA regulates the myogenesis of skeletal muscle satellite cells, injury repair and diseases</article-title><source>Cells</source><volume>8</volume><elocation-id>988</elocation-id><pub-id pub-id-type="doi">10.3390/cells8090988</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname> <given-names>M</given-names></name><name><surname>Liu</surname> <given-names>J</given-names></name><name><surname>Xiao</surname> <given-names>J</given-names></name><name><surname>Yang</surname> <given-names>L</given-names></name><name><surname>Cai</surname> <given-names>M</given-names></name><name><surname>Shen</surname> <given-names>H</given-names></name><name><surname>Chen</surname> <given-names>X</given-names></name><name><surname>Ma</surname> <given-names>Y</given-names></name><name><surname>Hu</surname> <given-names>S</given-names></name><name><surname>Wang</surname> <given-names>Z</given-names></name><name><surname>Hong</surname> <given-names>A</given-names></name><name><surname>Li</surname> <given-names>Y</given-names></name><name><surname>Sun</surname> <given-names>Y</given-names></name><name><surname>Wang</surname> <given-names>X</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Lnc-mg is a long non-coding RNA that promotes myogenesis</article-title><source>Nature Communications</source><volume>8</volume><elocation-id>14718</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms14718</pub-id><pub-id pub-id-type="pmid">28281528</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zuckerman</surname> <given-names>B</given-names></name><name><surname>Ulitsky</surname> <given-names>I</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Predictive models of subcellular localization of long RNAs</article-title><source>RNA</source><volume>25</volume><fpage>557</fpage><lpage>572</lpage><pub-id pub-id-type="doi">10.1261/rna.068288.118</pub-id><pub-id pub-id-type="pmid">30745363</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.54782.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Lee</surname><given-names>Jeannie T</given-names></name><role>Reviewing Editor</role><aff><institution>Massachusetts General Hospital</institution><country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Khalil</surname><given-names>Ahmad S</given-names></name><role>Reviewer</role><aff><institution>Boston University</institution><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p>Thank you for submitting your article &quot;Epigenetic regulation of Wnt7b expression by the cis-acting long noncoding RNA lnc-Rewind in muscle stem cells&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by a Senior Editor, a Reviewing Editor, and three reviewers. The following individual involved in review of your submission has agreed to reveal their identity: Ahmad S Khalil (Reviewer #2).</p><p>The reviewers have discussed the reviews with one another and the Editors. We will not be able to offer publication of the manuscript, at least not in the present form. You'll see that the reviewers have a number of criticisms and some feel that the data are of a preliminary quality that would need to be improved through additional experiments. While we cannot accept the current manuscript, we remain open to receiving a much revised version once you have had a chance to address the substantial concerns.</p><p>Summary:</p><p>LncRNAs serve as key regulators of gene expression and have recently been demonstrated to be involved in skeletal muscle development and disease. In this manuscript, Cipriano et al., characterize a novel lncRNA, lnc-Rewind, that acts a regulator of muscle stem cell proliferation through a cis-acting chromatin regulation mechanism. Using experiments with mouse cell lines and primary cells, they propose that lnc-Rewind is a conserved chromatin-associated lncRNA, whose expression is associated with muscle stem cell proliferation, that directly interacts with the methyltransferase G9a to mediate repression of Wnt7b.</p><p>Essential revisions:</p><p>1) Please provide direct evidence that lnc-Rewind interacts with the Wnt7b locus in cis. It would be ideal to perform a CHART/ChIRP/RAP experiment to determine if lnc-Rewind interacts with the Wnt7b locus. An RNA-DNA FISH would also be good to perform to determine the behavior of the RNA relative to the Wnt7b locus. Is the RNA confined to the locus or does it diffuse?</p><p>2) It is also not clear that lnc-Rewind directly interacts with G9a. Biochemical data will be required to demonstrate an interaction.</p><p>3) If lnc-Rewind upregulates 332 and downregulates 756 via Wnt7b derepression, an essential experiment would be to determine if Wnt7a overexpression in muscle cells results in a similar expression change.</p><p>4) Reviewer 3 questions how important Lnc-Rewind is to muscle homeostasis and differentiation; and how important is Wnt7b for the observed phenotype? Additional evidence to support the claims would be essential.</p><p>5) The percent of Lnc-Rewind precipitated with antibodies directed to G9a is very low. How much of the known G9a target Kcnq1ot1 precipitated in this assay? Is this background or a specific signal? More controls are required.</p><p>6) Furthermore, the H3K9me3 ChIP shows small differences between GAP-SCR (control) and GAP-REW (experiment), and the regions that were analyzed are located about 17-28 kb away from Wnt7b. We agree with Reviewer 3 that a ChIP with anti G9a would have been more informative, and a 4C analysis might show a connection between regions 91-94 and the Wnt7b gene.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.54782.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1) Please provide direct evidence that lnc-Rewind interacts with the Wnt7b locus in cis. It would be ideal to perform a CHART/ChIRP/RAP experiment to determine if lnc-Rewind interacts with the Wnt7b locus. An RNA-DNA FISH would also be good to perform to determine the behavior of the RNA relative to the Wnt7b locus. Is the RNA confined to the locus or does it diffuse?</p></disp-quote><p>Our initial RNA-FISH analyses evidenced a pattern of Lnc-Rewind fluorescence which is quite confined to discrete spots rather than being diffused through the nucleoplasm (Figure 1E and Figure 1—figure supplement 1F and 1G). These findings, together with the genomic proximity between <italic>Lnc-Rewind</italic> and <italic>Wnt7b</italic> genomic loci, gave a first piece of advice into a local, <italic>cis</italic>-acting, regulatory mechanism trough which Lnc-Rewind might modulate <italic>Wnt7b</italic> expression. In agreement with the need to provide a more direct evidence on the proposed <italic>in cis</italic> interaction, we have performed a double RNA/DNA FISH approach. Differently from CHART/ChIRP/RAP experiments, which are considered as population-based approaches, this assay allows a quantification of possible RNA/DNA proximities at single cell level. For this, we have labeled Lnc-Rewind RNA (BaseScopeTM technology) and <italic>Wnt7b</italic> locus (BAC clone Catalog#: RP23-272K17) with different fluorophores and used these FISH probes in MuSCs-derived myoblasts. Signal acquisition by confocal microscopy evidenced that ~47% of the Lnc-Rewind nuclear signals colocalize with <italic>Wnt7b</italic> locus (revised Figure 4D(b)). No proximity was instead found when an unrelated region (BAC clone, Catalog#: RP23-352B6 chromosome 7) was used as negative control (revised Figure 4D(a)). Importantly, in the revised version, we have also strengthened the evidence on the concomitant recruitment of Lnc-Rewind and G9a on <italic>Wnt7b</italic>. These data, which required the use of a new imaging set-up able to combine the RNA/DNA-FISH signals with the G9a immunofluorescence, clearly show the close proximity of both Lnc-Rewind and G9a signals with <italic>Wnt7b</italic> gene locus (revised Figure 5A). Overall, we believe that the dissection of the Lnc-Rewind mechanism of action has been considerably improved as a result of these revisions in further supporting its <italic>cis</italic>-acting role into the regulation of Wnt7b expression.</p><disp-quote content-type="editor-comment"><p>2) It is also not clear that lnc-Rewind directly interacts with G9a. Biochemical data will be required to demonstrate an interaction.</p></disp-quote><p>We thank the reviewer for having raised this point on the direct interaction between Lnc-Rewind and G9a whose clarification improved our experimental strategy and the general quality of the manuscript. Several evidences available in literature highlight the high rate of false positives identified by native IP analyses as many artificial interactions between RNA and proteins can occur in vitro after cell lysis (Colantoni et al., 2020; Cipriano et al., 2018; McHugh et al., 2014). Being aware of this limitation, in the previous version of the paper we already combined our native approach (RIP, Figure 4—figure supplement 1B) with another, crosslinked-based, protein-centric strategy (CLIP, revised Figure 4A). Please, kindly note that the CLIP, assay, which confirmed the specificity of Lnc-Rewind interaction with G9a, is recognized as the safest approach to detect <italic>direct</italic> interactions between RNA and proteins as the UV wavelength (254nm) is able to induce the crosslinking only if the RNA and the protein are in close contact (Ramanathan, et al., 2019). Based on the reviewers’ concern on the need of other biochemical data, we further applied an RNA pull-down approach allowing the purification of the <italic>endogenous</italic> Lnc-Rewind RNA and its interacting proteins. This analysis, which is RNA-centric and complementary to our initial RIP and CLIP experiments, strengthen our initial evidence by confirming the presence of G9a in Lnc-Rewind precipitated sample. These new results have been incorporated the revised Figure 4B and discussed in the subsection “Lnc-Rewind directly interacts with the methyltransferase G9a and mediates specific <italic>in cis</italic> repression of <italic>Wnt7b</italic> in MuSCs”. Additional support was provided, as discussed above, by the RNA/DNA-FISH/IF analysis showing a G9a/Lnc-Rewind concomitant recruitment on <italic>Wnt7b</italic> genomic locus (revised Figure 5A).</p><disp-quote content-type="editor-comment"><p>3) If lnc-Rewind upregulates 332 and downregulates 756 via Wnt7b derepression, an essential experiment would be to determine if Wnt7a overexpression in muscle cells results in a similar expression change.</p></disp-quote><p>While it is true that the expression of several genes is affected upon Lnc-Rewind knockdown, our transcriptomic data are not hierarchical and do not assume Wnt7b as the <italic>primum movens</italic> of the regulatory cascade downstream to Lnc-Rewind. Although some overlapping might exist, Wnt7b overexpression in muscle cells is not expected to globally modulate the same subset of Lnc-Rewind target genes. An additional issue is that Wnt7b ectopic expression will not necessarily mimic the overexpression level obtained upon Lnc-Rewind knockdown. It is well known that different levels of Wnt pathway activation give rise to diverse, and sometime opposite, phenotypes (Rudolf et al., 2016Β; Parisi et al., 2015; Figeac and Zammit, 2015). Therefore, unbalanced levels of Wnt7b overexpression might give rise to contradictory results. Nonetheless, to link the phenotype observed by Lnc-Rewind depletion to the induction of Wnt7b expression, we considered more straightforward to perform a rescue experiment. Thus, within a contest where the upregulation of Wnt7b was triggered by Lnc-Rewind depletion, we interfered with Wnt7b expression by siRNA-based knockdown. This experiment allowed us to show that restoration of Wnt7b to physiological levels is able to rescue the proliferation defects observed upon depletion of Lnc-Rewind. These results add an important piece of evidence supporting the role of Lnc-Rewind in sustaining MuSCs proliferation by controlling the expression of Wnt7b. These data are now discussed in subsection “Lnc-Rewind regulates muscle system processes and MuSCs” and included in the revised figures (revised Figure 3D,E and new Figure 3—figure supplement 1C).</p><disp-quote content-type="editor-comment"><p>4) Reviewer 3 questions how important Lnc-Rewind is to muscle homeostasis and differentiation; and how important is Wnt7b for the observed phenotype? Additional evidence to support the claims would be essential.</p></disp-quote><p>We agree with the reviewer on the importance of clarifying the impact of Wnt7b on the observed phenotype and we thank him/her for the input to provide additional evidence to strengthen our conclusion. As also described above, to fulfil reviewer’s request we performed a rescue experiment depleting Wnt7b expression upon Lnc-Rewind KD-induced upregulation (new Figure 3—figure supplement 1C). As shown in Figure 3E, this approach allowed us to uniquely demonstrate that the proliferation/activation defects observed on MuSCs depleted of Lnc-Rewind were rescued by restoring Wnt7b expression to control levels, through si-Wnt7b treatment. Of note, we proved this on both MuSCs-derived myoblasts (revised Figure 3D) and in myofibers-associated MuSCs (revised Figure 3E), consolidating our conclusion on a direct role of Lnc-Rewind-mediated Wnt7b repression in sustaining MuSCs proliferation and activation. These data are now discussed in subsection “Lnc-Rewind regulates muscle system processes and MuSCs”.</p><disp-quote content-type="editor-comment"><p>5) The percent of Lnc-Rewind precipitated with antibodies directed to G9a is very low. How much of the known G9a target Kcnq1ot1 precipitated in this assay? Is this background or a specific signal? More controls are required.</p></disp-quote><p>The low percentage of Lnc-Rewind precipitation might be imputable to a general limitation of native RIP. Please kindly note that, indeed, higher levels of enrichments were obtained by CLIP assay (25% of the input, revised Figure 4A, right panel) when the interaction between Lnc-Rewind and G9a was stabilized by UV-cross-linking. As requested, we have quantified the levels of Kcnq1ot1 precipitation and found similar levels of Lnc-Rewind enrichment (see new Figure 4—figure supplement 1B). Together with the biochemical experiments discussed at point <italic>#</italic>2, the above results unequivocally confirm a direct and specific interaction between Lnc-Rewind and G9a. We thank the reviewer for his/her pertinent comment, which has helped to improve our data and to clarify the details of the proposed model.</p><disp-quote content-type="editor-comment"><p>6) Furthermore, the H3K9me3 ChIP shows small differences between GAP-SCR (control) and GAP-REW (experiment), and the regions that were analyzed are located about 17-28 kb away from Wnt7b. We agree with Reviewer 3 that a ChIP with anti G9a would have been more informative, and a 4C analysis might show a connection between regions 91-94 and the Wnt7b gene.</p></disp-quote><p>The choice for these regions was driven by data already available in Mozzetta’s lab, and derived from G9a ChIP-seq analyses performed in C<sub>2</sub>C<sub>12</sub> (not shown), which revealed the presence of several G9a enriched peaks upstream <italic>Wnt7b</italic>, in particular on the region that is proximal to TSS. In agreement with the need to better specify the reason why these amplicons were prioritized, we have included the G9a ChIP analyses in the revised version (see new Figure 4—figure supplement 1C ) and showed by qPCR that (i) these regions are significantly enriched in G9a and that (ii) at these sites, the levels of G9a enrichment was even higher than <italic>Myogenin</italic>, known G9a-target (Ling et al., 2012). In further support of a role for G9a in mediating Wnt7b repression, we also provide evidence that G9a knock-down induces upregulation of <italic>Wnt7b</italic> mRNA levels on MuSCs. These new data are shown in the revised Figure 4C and commented in subsection “Lnc-Rewind directly interacts with the methyltransferase G9a and mediates specific <italic>in cis</italic> repression of <italic>Wnt7b</italic> in MuSCs”.</p></body></sub-article></article>